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ABSTRACT 
 
Polyploidy is the condition in which a cell possesses more than 
two sets of homologous chromosomes. Although polyploidy is 
not common in mammalians, some specific tissues including 
heart, muscle cells, megakaryocytes, trophoblast giant cells and 
parenchyma liver cells are physiologically polyploid. In liver 
an extensive polyploidization occurs during the weaning period 
between the 15
th
 and 40
th
 day after birth, leading to the 
formation of tetraploid and octapoloid cells with one or two 
nuclei. Polyploid hepatocytes retain an highly proliferative 
potentiality; they can undergo multipolar mitosis due to extra 
centrosomes generating 3 or 4 aneuploid daughter cells. 
Hepatic aneuploidy was proposed to be a substrate for selection 
of more resistant clones during liver injury. In fact it has been 
demonstrated that specific aneuploid injury resistant nodules 
emerged after chronic liver damage. However, how 
polyploidization is triggered, established and regulated remains 
an open question. Several data suggest that micro-
environmental elements (mainly soluble factors), rather than 
cell autonomous mechanisms, play a direct role in the 
appearance of polyploidy. For example, insulin and T3 
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hormone were identified as positive regulators and TGFα as a 
negative regulator of the binucleation. We screened the effects 
of a set of soluble factors involved in liver development and/or 
mass liver control on a murine hepatocyte cell line. Within the 
screening, we identified the cytokine TGFβ as a strong inducer 
of hepatocyte binucleation. Time lapse video microscopy 
highlighted that binucleated cells originated from a mechanism 
of cytokinesis failure without affecting the kinetics of the 
mitosis; this suggests that binucleation is a physiological 
alternative program of hepatocyte division. Very interestingly, 
in vivo experiments performed with the oral administration of a 
TGFβ receptor chemical inhibitor, during days 18-32 post-birth 
in mice, produced a significant decrease of binucleated 
hepatocytes, confirming the crucial role played by this cytokine 
in the polyploidization of the liver cells. In-vivo data showed 
that the hepatocytes cellular model recapitulated the 
physiology of the whole organism. Analysis of TGFβ 
downstream elements, known to be involved in cytoskeleton 
rearrangement, showed that Src kinase activity has a role in the 
polyploidization process of hepatocytes, most probably through 
the control of the GTPase protein RhoA, an actin cytoskeleton 
regulator, crucial for the cytokinesis. In TGFβ treated cells, in 
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fact, together with the activation of Src, we observed a 
delocalization from the mid-body structure of the active form 
of RhoA. TGFβ is well known to trigger Epithelial to 
Mesenchymal Transition (EMT) in hepatocytes. The TGFβ-
induced binucleated cells, in fact, showed a fibroblastoid 
morphology with upregulation of mesenchymal markers and 
downregulation of epithelial ones. TGFβ withdrawal was also 
performed and it produced an increase in ploidy levels with the 
appearance of an octaploid population and giant nuclei. 
Together with a ploidy increase, TGFβ withdrawal triggered 
the Mesenchymal to Epithelial Transition (MET) characterized 
by upregulation of ephitelial markers and downregulation of 
mesenchymal markers and generating a full epithelial 
polyploid population. In conclusion, TGFβ seems to be one of 
the major stimuli for hepatocyte binucleation; it acts through 
Src kinases and involves the activity of RhoA during 
cytokinesis. Moreover, intriguing is the relationship between 
EMT/MET and polyploidization  that might reveal a new 
biological process in which these transdifferentiation 
mechanisms are involved and thus, requires further study. 
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CHAPTER 1. INTRODUCTION 
1. Epithelial-to-mesenchymal transition in the liver 
 
1.1 The liver 
The liver is the largest solid organ of the body. It is provided 
with a dual blood supply. Approximately 75% of the blood 
entering the liver is venous blood filled with nutrients and toxic 
substances from the portal vein, drained from the spleen, 
gastrointestinal tract, and its associated organs. Liver plays a 
pivotal role in metabolic conversion of nutrients and 
xenobiotics and release them into the blood and bile. Hepatic 
parenchyma is made up of two cell types: hepatocytes (about 
70-75% of hepatic cells) and cholangiocytes (10-5%). Both 
derive from the anterior portion of the definitive endoderm, 
which is established in the embryo during gastrulation. The 
stromal compartment of the liver includes hepatic sinusoidal 
endothelial cells, hepatic stellate cells (HSCs), and Kupffer 
cells (KC). Sinusoids are the first blood vessels to form during 
hepatogenesis, they develop by angiogenesis from existing 
vessels in the septum trasversum mesenchyme. Sinusoidal 
Introduction - Ephitelial-to-Mesenchymal transition in the liver 
12 
 
endothelial cells, supplied of multiple fenestrations, facilitate 
transfer of factors between the sinusoidal lumen and the 
surface of the hapatocytes (Si-Tayeb et al. 2010). Kupffer cells 
are resident macrophages on the surface of hepatic sinusoidal 
endothelial cells. They represent 15% of the liver cell 
population and 50% of resident macrophages in the body 
(Figure 1). Thus, the liver is composed of both mesenchymal 
and epithelial cells and a process called ephitelial-to-
mesenchymal transition play a crucial role during liver 
development/morphogenesis and chronic degenerative 
processes. 
 
Figure 1 Architecture of hepatic parenchyma. Liver comprises 
about 60-80% of hepatocytes arranged in an epithelial 
monolayer called hepatic cord. The basolateral hepatocyte 
surface is lined with a fenestrated endothelium, formin 
sinusoidal vessels. The apical face of adjacent hepatocytes 
forms bile canaliculus. Other intrahepatic cell populations 
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include biliary cells, liver sinusoidal endothelium cells 
(LSECs), resident macrophages called Kupffer cells and 
hepatic stellate cells, located in the Disse space between 
hepatocytes and LSECs. From Adams and Eksteen 2006. 
1.2 Epithelial-to-Mesenchymal and Mesenchymal-to-
Epithelial transitions. 
Epithelial cells are adherent cells that closely attach to each 
other, forming coherent layers in which cells exhibit apico-
basal polarity. In contrast, mesenchymal cells are non-
polarized cells, capable of moving as individual cells because 
they lack intracellular connection. An epithelial-mesenchymal 
transition (EMT) is a biological process that allows a 
polarized epithelial cell which normally interacts with 
basement membrane via its basal surface, to undergo multiple 
biochemical changes that enable it to assume a mesenchymal 
cell phenotype. Moreover, a new transcriptional program is 
induced to maintain the mesenchymal phenotype (Grünert at al. 
2003). EMT is a complex, extreme manifestation of cellular 
plasticity that involves an orchestrated series of events. The 
key to EMT is the reduction of cell-cell adhesion by 
transcriptional repression of cadherins (adherent junctions), 
occludin and claudin (tight junctions) and desmoplakin 
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(desmosomes). Repression of E-cadherin transcription is 
accompanied by induction of N-cadherin (neural cadherin) or 
cadherin-11 expression, that is known as the cadherin switch. 
Other major changes in cytoskeleton organization and 
composition are the replacement of F-actin fibers by the Rho-
mediated network of the stress fibers at the tip of which ECM 
adhesion molecules localize, including integrins and integrin 
linked kinase (Fuchs et al 2008). Those changes are sufficient 
for the cells to separate, lose apico-basal polarity and gain a 
spindle shape (Hugo et al. 2007) (Figure 2). A hallmark of 
EMT is its reversibility. The phenotypic plasticity afforded by 
an EMT is revealed by the occurrence of reverse process, a 
mesenchymal-epithelial transition (MET), which involves 
the conversion of mesenchymal cells to epithelial derivatives 
(Thiery et al., 2009). 
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Figure 2 Epithelial-to-mesenchymal transition. The transition 
encompasses a broad spectrum of phenotypic changes from a 
transient loss of cell polarity to a total cellular reprogramming. 
Transitional cells which display an intermediate phenotype 
(coexistence of both epithelial and mesenchymal markers) have 
also been detected. Epithelial and mesenchymal markers 
commonly modulated during the EMT/MET transition are 
listed. From Kalluri and Weinberg 2009 
1.3 Physio-pathological situations associated with 
EMT/MET 
EMT and the reverse process MET are strongly involved in 
embryogenesis and development. However, it is important to 
emphasize that EMT/MET refer to changes in cell shape and 
adhesive properties. Cell fate (lineage) is specified by other 
mechanisms (Choi and Diehl 2009). Hence, EMT/MET are 
merely manifestations of the inherent plasticity (Kalluri 
2009). EMT during embryogenesis is the formation of the 
primitive streak, which leads in turn to the formation of the 
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three germ layers, including the formation of mesenchymal 
cells and mesoderm that generate all tissue types of the body. 
Indeed, mesodermal and endodermal cells can undergo MET to 
generates secondary epithelia that than undergoes further 
rounds of EMT/MET to form various organs (Figure 3). 
Moreover, the formation of placenta, somites, heart valves, 
neural crest, uro-genital tract and secondary palate, and 
branching morphogenesis of multiple different organs all 
involve EMT (Savagner 2001, Nieto et al. 2009). In this 
scenario EMT/MET are fundamental processes parallel to 
differentiation and/or associated with the building or 
remodelling tissues. It is used whenever high motility and loss 
of polarity is needed. It has been shown that also adult cells are 
capable to undergo EMT/MET. Liver adult cells such as 
hepatocytes, choloangiocytes and hepatic stellate cells (HSC) 
are best known to undergo in EMT/MET. In fact, several 
groups including us have demonstrated in-vitro that treating 
primary murine hepatocytes or non-tumorigenic hepatocytes 
cell lines with TGFβ cytokine causes them to down regulate 
expression of epithelial genes and up regulate expression of 
mesenchymal genes (Spagnoli et al. 2000, Kaimori at al. 2007, 
Zeisberg et al. 2007). In-vivo EMT/MET of adult liver cells are 
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associated with the replacement of dead or damaged epithelial 
cells with healthy new epithelial cells (Figure 3).  
 
Figure 3 EMT can occur when tissues are built during 
embryogenesis/development and during adult tissue 
remodeling responses such as injury. During adult liver injury, 
EMT promotes liver repair. EMT facilitates transient 
acquisition of a mesenchymal phenotype by certain types of 
liver epithelial cells. Epithelia-derived mesenchymal cells may 
contribute to liver fibrosis or they can revert to epithelial cells 
by MET process. EMT/MET is an intermediate step to form 
new hepatocytes and cholangiocytes. Recent fate-mapping 
studies in transgenic mice suggest that MET may have a role in 
hepatocyte regeneration. From Choi and Diehl 2009 
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The best known example of EMT/MET of liver adult cells is 
the response to liver injury. The normal mammalian response 
to injury occurs in three overlapping but distinct stages: 
inflammation, new tissue formation, and tissue remodelling 
(Gurtner et al. 2008). The latter two processes are known as 
liver regeneration. For example, after 2/3 hepatectomy, most 
hepatic cells rapidly enter the cell cycle and undergo an 
average of approximately 1.6 cycles of replication per cell to 
completely restore the original liver mass (Taub 2004). The 
regenerative response is mostly mediated by two groups of 
components: growth factors and cytokines, i.e. interleukin-6 
(IL-6), tumor necrosis factor (TNF), epidermal growth factor 
(EGF) and transforming growth factor (TGFβ). TNF binds its 
type I receptor, leading to nuclear factor kappa B activation in 
Kuppfer cells, which produce IL-6 and TNF; IL-6 is 
subsequently released into the serum and binds to its receptor 
to activate the STAT-3 signaling pathway to initiate hepatocyte 
regeneration (Fausto et al. 2006). EGF and TGFβ have been 
identified as promoters of EMT (Figure 4) (Pagan et al. 1997, 
Pagan et al. 1999, Valdes et al. 2002). Indeed, TGFβ that is 
mostly released from hepatic stellate cells (HSC) can directly 
activate adjacent hepatocytes through Smad signaling and 
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induce EMT. Based on the intensity and/or persistence of the 
injury a partial and complete EMT are possible. In the partial 
EMT (or EMT-like) the cells coexpress both epithelial and 
mesenchymal markers (such as cytokeratins, albumin, E-
cadherin as epithelial genes and vimentin, collagen-I as 
mesenchymal genes) (Kalluri and Weinberg 2009). The MET 
process on these EMT-like cells is associated with gain of 
regeneration and production of new hepatocytes (Figure 4). 
Nevertheless, a continuous insult can lead to a persistence of 
EMT-like cells in a mesenchymal phenotype that accumulate. 
In these condition a complete EMT occurs together with the 
upregulation of Snail transcription factor and deposition of 
extracellular matrix (ECM) collagen 1/3 and elastin that 
triggers the fibrotic process (Figure 4). In fibrotic tissues, 
myofibroblasts accumulate and secrete an excessive amount of 
collagen that is deposited as fibers, thereby compromising 
organ function and leading to its failure. In conclusion, the 
balance between EMT and MET modulates the outcomes of 
liver injury. When EMT activity exceeds MET, repair is 
mainly fibrogenic, causing fibrosis. Conversely, predominance 
of MET favours more normal liver regeneration (Choi and 
Diehl 2009). 
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Figure 4 Liver regeneration and EMT. Different insults initiate 
inflammation and then cause hepatocyte stellate cells (HSCs) 
activation and hepatocyte damage. HSCs secrete a key 
cytokine TGFβ that affects normal hepatocytes and promote 
EMT. Partial EMT followed by MET produces new healthy 
hepatocytes (regeneration). Continuous insult shifts partial 
EMT cells to complete EMT cells and finally myofibroblasts, 
the main producer of extra cellular matrix, leading to fibrotic 
process and loss of regenerative capacity . Modified from Xue 
et al 2013 
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1.4 Molecular signalling in EMT: TGFβ 
Multiple extracellular signals can initiate an EMT program, and 
there is a significant crosstalk among the downstream intracellular 
signaling pathways and transcription factors that orchestrate this 
complex process. Growth factors acting through tyrosine kinase 
receptors (EGF, FGF2, IGF-II, HGF and PDGF), TGFβ, Wnt, 
Notch, integrins, endothelin A receptor (ETAR) appear to be 
responsible for the induction or functional activation of a series of 
EMT-inducing transcription factors, such as Snail, Slug, zinc 
finger E-box binding homeobox1 (ZEB1), Twist, Goosecoid, and 
FOXC2 (Moustakas and Heldin 2007). Members of the TGFβ 
superfamily are the major and the best characterized inducers 
of EMT. The TGFβ superfamily is composed of the TGFβ 
isoforms (TGFβ1, 2 and 3), Activin, Nodal, bone 
morphogenetic proteins (BMPs), growth and differentiation 
factor (GDF), and Mullerian inhibitory factor (MIF). The 
active form of TGFβ is a 25kDa dimer in which the two 
polypeptides interact via a disulfide bond and hydrophobic 
interactions. Once activated, TGFβ family members initiate 
signaling by interacting with and leading to the activation of 
two receptor serine/threonine kinases referred to as the type I 
and type II receptors, forming a heterotetrameric active 
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complex. There are seven known mammalian type I receptors 
termed ALK1-7 (activin receptor-like kinase) and five type II 
receptors. Due to the multipliclicity of receptor class 
combinations, no cross link between different ligands and the 
same receptor has been identified (Ehrlich et al. 2011). TGFβ 
utilizes ALK5 (TβR-I) and TβR-II receptors in the vast 
majority of cell types (Rahimi et al. 2007). The most well 
characterized mechanism whereby TGFβ initiate signal 
transduction is via the phosphorylation and activation of the 
Smad 2/3 and 4 proteins. This transduction pathway is known 
as canonical TGFβ pathway. Phosphorylated Smad proteins 
translocate to the nucleus where they accumulate and 
collaborate with other transcription factors to regulate gene 
expression. This pathway converges to the induction of the E-
cadherin transcriptional repressors such as SNAIL1, SLUG, 
ZEB2 and E47, which directly represses E-cadherin 
transcription (Peinado et al. 2003) (Figure 5). In particular, 
Smad3 has been shown to upregulate the zinc-finger 
transcription factor Snail, which represses the transcription of 
E-cadherin (Cho et al. 2007). These transcriptional factors act 
as “EMT master genes”, since their overexpression in epithelial 
cells not only results in loss of E-cadherin but also in a total 
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cellular reprogramming towards a mesenchymal state, through 
the downregulation of adhesion molecules (cytokeratins, 
integrins, occludins and ZO proteins) and the induction of 
mesenchymal features in a coordinated manner (Peinado et al. 
2007).  
 
 
Figure 5 The smad-dependent TGFβ downstream pathway. 
Activation of tetrameric complex 2X TβR-1/TβR-II causes the 
phosphorylation of Smad2/3 which then forms a complex with 
Smad4. Activated Smad 2/3 and 4 complex translocates into 
the nucleus and drives the transcription of Snail that is regarded 
to be a master gene of the EMT process. 
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Other downstream pathways activated by TGFβ are referred to 
as non-Smad pathways, which also play an important role to 
trigger the EMT process.  
Erk/MAPK pathway: Activation of TGFβ receptor causes the 
loading of GTP on Ras oncogene (Mulder and Morris 1992). In 
its GTPbound state, Ras can bind Raf and activate a MAPK 
(Mitogen-activated protein kinase) cascade that includes MEK 
and Erk (Hartsough and Mulder 1995). Activation of this 
pathway is necessary to trigger the EMT in combination with 
the canonical pathway. Indeed, Erk activation is required for 
disassembly of cell adherents junctions and induction of cell 
motility by TGF-β. The activated form of Erk can also interact 
with Smad proteins such as Smad 2/3 and 7 and regulate their 
activities (Matsuura et al. 2005). Inhibitory phosphorylation of 
Smads by Erk was proposed as a mechanism to explain how 
oncogenic Ras overrides TGF-β-mediated growth arrest in 
cancer cells (Kretzschmar et al. 1999) (Figure 6). 
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Figure 6 The Erk non-Smad pathway. TGF-β can induce 
phosphorylation of tyrosine residues on both type I and type II 
receptors. The phosphorylated tyrosines are capable to activate 
Erk through Ras, Raf, and their downstream MAPK cascades. 
Erk then regulates target gene transcription through its 
downstream transcription factors in conjunction with Smads to 
control EMT. Erk can also inhibit Smad activities through 
phosphorylation of Smads. From Zhang 2009. 
PIP3/Akt pathway: TGFβ is known to cause the activation of 
the phosphoinositide 3-kinase (PI3K)-Akt, through the 
regulatory subunit p85 associated to the TβR-I (Edlund et al. 
2005, Yi et al. 2005). Despite the fact that the molecular 
mechanism is not well characterized, recent studies have 
demonstrated that TGFβ regulates the mammalian target of 
rapamycin (mTOR) kinase in an Akt-dependent manner. 
Activation of this pathway regulates metabolism, migration, 
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and invasion (Lamouille and Derynck 2007, 2011) features of 
the EMT process. Moreover it was shown that the PI3K/Akt 
pathway antagonizes Smad-mediated effects. For example, 
activation of PI3K or Akt protects cells from TGF-β-induced 
apoptosis and growth inhibition (Chen et al. 1998, Song et al. 
2006). This protection has been suggested to result from a 
physical interaction between Akt and Smad3 that prevents 
TβRI-mediated phosphorylation (Remy et al. 2004) (Figure 7). 
 
Figure 7 The PI3K/Akt non-Smad pathway. TGF-β can 
activate PI3K and Akt, possibly by inducing a physical 
interaction between the p85 subunit of PI3K and the receptors. 
The activated PI3K/Akt pathway then controls translational 
responses through mTOR, which collaborates with Smad-
mediated transcriptional responses during EMT. Akt is also 
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capable of antagonizing TGF-β-induced apoptosis and growth 
arrest by sequestering Smad3 in the cytoplasm and by 
inhibiting the activity of FoxO transcription factor. From 
Zhang 2009. 
Rho-like GTPase pathway: Rho-like small GTPase, including 
RhoA, Rac and Cdc42 plays a fundamental role in cytoskeleton 
rearrangement, organization and cell motility. It has been 
reported that TGFβ-dependent modulation of this pathway is 
independent of Smad 2/3 protein activation and it produce a 
short term response after the TGFβ stimulation (Bhowmick et 
al. 2001). Activation of this pathway mediates a short term 
response to TGFβ because they do not directly comprise 
regulation of gene expression. TGF-β rapidly activates RhoA-
dependent signaling pathways to induce stress fiber formation 
and mesenchymal characteristics in epithelial cells and primary 
keratinocytes (Bhowmick et al. 2001). Indeed, RhoA is a 
common effector of different mechanisms involving 
cytoskeleton arrangement. Different mechanisms may use 
different GTPase regulators conferring specificity: the 
inhibitors are GTPase-activating proteins (GAPs) and the 
activators are guanine nucleotide exchange factors (GEFs). In 
the EMT process, RhoA regulation involves at least two 
different GEFs, Net1 (Shen et al. 2001, Papadimitriou et al. 
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2012) and Vav2 (Papadimitriou et al. 2011). However, 
downregulation of RhoA protein levels at tight junctions by 
TGF-β has also been reported. TβR-II phosphorylates Par6 that 
recruits Smarf1. The complex Par6/Smurf1 drives localized 
ubiquitination and turnover of RhoA at cellular protrusions 
(Ozdamar et al. 2005). Thus, downregulation activity of RhoA 
is restricted to particular subcellular sites. In conclusion, rapid 
activation and localized degradation of RhoA are parallel 
effects of TGFβ stimulation and both appear to be necessary 
for EMT (Figure 8). 
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Figure 8 The Small GTPase non-Smad pathway. RhoA can be 
activated by TGF-β via either Smad-dependent or independent 
routes to induce actin stress fiber formation during EMT. TGF-
β also induces the dissolution of tight junctions during EMT by 
recruiting Cdc42 to the receptor complex, and by triggering 
degradation of RhoA at cellular protrusions. TGF-β-induced 
RhoA degradation requires phosphorylation of Par6 by TβRII 
and the Smurf1 E3 ligase. From Zhang 2009. 
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2. Liver polyploidy 
 
2.1 Polyploidy among mammalian organisms 
Polyploidy is the state in which cells possess more than two 
sets of homologous chromosomes. Polyploidy is a widespread 
physiological phenomenon observed particularly in plants, 
fungi, insect, fish and amphibians (Otto 2007). Although 
polyploidy is not common in mammalians, some specific 
tissues are physiologically polyploid. Indeed, polyploidy seems 
to be part of the developmental program resulting in the 
formation of highly differentiated cells, as it has been reported 
for megakaryocytes (Winkelmann at al. 1987), cardiomyocytes 
(Brodsky et al. 1980), trophoblast giant cells (Ullah et al. 
2008), Purkinje neurons (Lapham 1968), retinal ganglion cells 
(Morillo et al. 2010) and finally for hepatocytes of the liver 
parenchyma (Gupta 2000). Despite the importance of 
polyploidy in mammalians, the knowledge about its functions 
is very poor. The biological significance of polyploidy has 
been explained as gene amplification. A double genome simply 
doubles gene expression without modulating the transcriptional 
machinery (Storchova et al. 2006). Moreover, increased DNA 
content also increases cellular size. It was hypothesized that 
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cell size might provide a metabolic benefit (Comai 2005). 
Polyploid cells have an intrinsic gene redundancy within the 
genome. Having multiple copies of the same allele might, in 
principle, protect polyploid cells from deleterious mutations 
(Comai 2005). For example, loss of a tumor suppressor on one 
or both homologs in a diploid cell could have disastrous 
consequences. Finally, it was demonstrated that polyploid cells 
are a substrate for the formation of aneuploidy. This aspect will 
be described in more detail in the next sections. 
2.2 Routes to polyploidy  
In physiological and pathological conditions polyploid cells 
can arise by at least four well-known processes with different 
outcomes. During cell-cell fusion genesis of polyploid cells 
may occur independently of cell proliferation. In this process, 
mononucleated cells fuse their plasma membranes, leading to 
the formation of a binucleated cell with a double number of 
centrosome (Figure). Cell-cell fusion has been observed during 
physiological development of osteoclast and skeletal muscle 
cells (Vignery 2000, Taylor 2002). Certain virusses can induce 
cell-cell fusion with as side effect the fusion of  different cell 
types together, leading to pathological states.  
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Endoreduplication is another mechanism for the genesis of 
polyploid cells. During this process proliferative cells alternate 
S (DNA replication) and G phases of the cell cycle without 
performing mitosis (Figure 9). The result is a mononucleated 
cell with a high grade of DNA content that depends of the 
number of the endoreduplication rounds (Lilly and Durino 
2005). The number of centrosomes is also doubled as 
replication of centrosomes takes place in conjunction with the 
replication of DNA during the S phase (Figure 9). The best 
characterized example of endoreduplication occurs during 
placenta development, when trophoblast stem cells that are 
deprived of fibroblast growth factor 4 (FGF4) differentiate into 
trophoblast giant cells (TGCs). This switch is dependent of the 
inhibition of cyclin dependent kinase 1 (CDK1), that is 
required for mitosis, and on the activity of CDK2 which 
promotes S phase (Ullah et al. 2008). Endomitosis is a variant 
of mitosis and is well known to characterize the cell cycle of 
the megakaryocytes (Ravid et al. 2002). These cells enter in 
and progress through mitosis until the metaphase but never 
fully separate sister chromatids in anaphase or undergo 
cytokinesis. It results in mononucleated globule polyploid cells 
(Figure 9). It was shown that endomitosis in megakaryocytes is 
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promoted by the downregulation of CylcinB kinase activity, 
necessary for the metaphase/anaphase transition, and the 
upregulation of Cyclin E which promotes the progression in G1 
phase (Zhang et al. 1998, Eliades et al. 2010).  
 
Figure 9 Different mechanisms for the genesis of polyploid 
cells. Cell-cell fusion results in a binucleated cell with double 
number of centrosomes. Endoreduplication: the cell proceeds 
into cell cycle without mitosis stage resulting in the formation 
of a mononucleated tetraploid cell with double number of 
centrosomes. Endomitosis: mitosis stage is performed without 
separation of sister chromatids and cytokinesis resulting in a 
mononucleated tetraploid cell. From Gentric and Desdouets 
2013 
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The last mechanism that leads to the formation of polyploid 
cells involves cytokinesis. Cytokinesis is the physical 
separation of one cell into two daughter cells and it is the last 
step of the cell cycle. It is often referred as C phase of the cell 
cycle (Canman et al. 2000) because it is highly coordinated 
with the other phases and it uses both specific and shared 
molecular machineries. The cytokinesis onset is marked by 
cleavage plane specification in which proteins required for 
furrowing accumulate at the equator cortex in a microtubule-
dependent manner (Eggert et al. 2006). Specification of the 
cleavage plane depends on RhoA GTPase that is necessary for 
completion of cytokinesis (Melendez et al. 2011). RhoA 
activity is regulated by specific RhoA GEFs and GAPs that 
mediate the turnover of GTP and GDP. The best known are the 
GEF Ect2 (epithelial transforming sequence 2) and the GAP 
McgRacGAP (male germ cell Rac GAP). Ect2 and 
McgRacGAP form a complex with the mitotic kinesin-like 
protein MKLP1 that is responsible of the contractile ring 
localization of the whole complex (Yuce et al. 2005, Kamijo et 
al. 2006, Nishimura and Yonemura 2006) (Figure 10). Indeed, 
localized activity of RhoA GTPase at the equatorial membrane 
provides both filamentous actin assembly and myosin-II 
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recruitment forming the actomyosin ring structure. Contraction 
of this structure is also mediated by the activity of RhoA and 
leads to the furrow ingression (Pienkny et al. 2005). When the 
cleavage furrow has fully ingressed it compresses the midzone 
and an intercellular bridge called midbody is created (Figure 
10).  
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Figure 10 Stages and main actors of cytokinesis. A) 
Specification of the cleavage plane. Red marker identifies the 
equatorial cortex where actin and myosin II are recruited to 
form the contractile ring. Contraction of the actomyosin ring 
depends on the localized activity of RhoA. B) Contraction of 
the actomyosin ring leads to the ingression of the cleavage 
furrow. C) Last stage of cytokinesis in which cells are 
connected with a cytoplasmic bridge called mid-body. D) 
RhoA forms a complex with MKLP1 necessary for the 
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localization to the equatorial zone, the GEF Ect2 and the GAP 
McgRacGAP that regulates the activity of RhoA. A, B, C 
Modified from Eggert et al 2006 
Completion of cytokinesis occurs when the intercellular bridge 
is resolved creating two daughter cells. Aurora B kinase has an 
important role during the cytokinesis completion (abscission). 
This kinase localizes to the midzone associated with the 
microtubule and equatorial cortex, accumulating ultimately at 
the midbody (Carmena et al. 2009). It is a key regulator of the 
abscission timing if unsegregated chromatin is trapped at the 
furrow ingression site in human cells. In cells with chromatin 
bridges between daughter nuclei, active Aurora B persists in 
the intercellular bridge stabilizing the bridge and delaying the 
abscission (Steigemann et al. 2009). Cytokinesis failure can 
occur following dysfunction of anyone of the necessary 
proteins described above. Depending on which molecular 
mediator is compromised, the cytokinesis stage can show a 
partial furrowing followed by regression of the cleavage furrow 
or a full absence of contracting activity (Eggert et al 2006). 
Moreover, the chromatin bridge also leads to regression of the 
cleavage furrow and cytokinesis failure in an Aurora B 
dependent manner (Steigemann et al. 2009). In this case the 
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cytokinesis stage is often strongly delayed, aborted and finally 
the cell progresses into the next G1 phase after few hours due 
to degradation of Cyclin B. Irrespective of the molecular 
mechanism involved, cytokinesis failure produces a tetraploid 
binucleated cell. Increase in cellular DNA content is associated 
with two centrosomes in the same cytoplasm (Storchova and 
Pellman 2004) (Figure 11). 
 
 
 
Figure 11 Cytokinesis failure mechanism. Diploid cells 
undergo a normal cell cycle and progress into all the phases of 
mitosis. However cytokinesis is impaired with the formation of  
tetraploid binucleated cells with double centrosome number. 
Modified from Gentric and Desdouets 2013 
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2.3 Polyploidy in liver 
Hepatic development is an extended process that continues 
through early post-natal life. In murine liver, at 14 days post-
coitus most of the hepatoblasts are bipotent with the ability to 
renew into hepatoblast or differentiate into biliary cells. 
However, by 15 days post-coitus most hepatoblasts are 
committed to the hepatocytes lineage. During the last period of 
gestation and the first post-natal month, hepatoblasts 
differentiate in hepatocytes (Germain et al. 1988, Shiojiri et al 
1991, Gentric et al 2012). In parallel with hepatocyte lineage 
specification begins a process to increase ploidy . Mammalian 
liver at birth is fully composed of mononucleated diploid 
hepatocytes. However, during the first 4 weeks after birth an 
extensive polyploidization takes place in the parenchyma in 
which tetraploid (4n) and octaploid (8n) hepatocytes 
accumulate. Kinetics of liver polyploidization has been 
analyzed on liver slice by quantitative fluorescent microscopy, 
a technique that allows discriminating number of nuclei and 
relative DNA content. After weaning (day 17 post-birth), the 
proportion of diploid hepatocytes started to fall significantly, 
with the successive appearance of binucleated tetraploid and 
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then also mononucleated tetraploid hepatocytes (Guidotti et al. 
2003) (Figure 12).  
 
Figure 12 Kinetics of liver binucleation. A) Quantitative 
fluorescent analysis of DNA stain (blue) allows to discriminate 
diploid nuclei from tetraploid nuclei. Β-catenin stain (red) 
allows to discriminate mononucleated form binucleated cells. 
B) Percentage of diploid mononucleated, tetraploid 
mononucleated and tetraploid binucleated hepatocytes during 
the first month of development in mouse. From Celton-Morizur 
et al. 2010 
The hepatocyte ploidy levels reaches a plateau at maturity with 
binucleated and mononucleated octaploid hepatocytes 
appearing during the second month after birth (Seglen 1997). 
In the adult healthy liver the percentage of polyploid 
hepatocytes is variable between mammals. For example 80% 
of adult rat hepatocytes are polyploid, whereas the average in 
human is 50% (Seglen et al. 1997, Toyada et al. 2005).  
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Polyploid hepatocytes in the adult organism are equally 
distributed in the hepatic lobule, in fact similar proportions of 
binucleated hepatocytes are present in both periportal and 
perivenous areas (Margall-Ducos et al. 2007). During the adult 
age ploidy levels remain stable among the healthy lifespan. 
However certain pathological conditions increase ploidy levels. 
In the adult liver hepatocyte turnover occurs slowly in which 
less than 0.1% of hepatocytes are cycling at any given time 
(Fausto and Campbell 2003). Although hepatocytes are mostly 
quiescent in non-injury situations, these cells retain high 
regenerative potential in response to liver injury. For example, 
rats regenerate their livers in response to seven sequential 50% 
partial hepatectomies (Stocker at al. 1973). During the 
regenerative process after partial hepatectomy quiescent 
hepatocytes are able to enter in the cell cycle and restore the 
liver mass in response to mitogenic signals (Michalopoulos 
2007). It was demonstrated that during this process the ratio of 
binucleated cells decreases to less than 5% while there is an 
increase in tetraploid and octaploid mononucleated hepatocytes 
(Sigal et al. 1999) (Figure 13). Another pathological condition 
that leads to an increase in polyploidy is the metabolic overload 
that induces liver lesions (Gentric at al. 2011). For example 
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long Evans Cinnamon (LEC) rats, a murine model that shares 
the clinical characteristics of human Wilson‟s disease, show 
excess of iron and cupper in the liver. In this model liver 
polyploidy is increased and giant mononucleated polyploid 
hepatocytes are present in the liver mass (Muramatsu et al. 
2000, Troadec et al. 2006) (Figure 13). Finally, oxidative 
damage to the liver is also associated with pronounced increase 
of polyploid hepatocytes (Gorla et al. 2001) (Figure 13). In line 
with this data it was demonstrated that overexpression of 
antioxidant enzymes (i.e. glutathione peroxidise) in transgenic 
mice decreases hepatocytes ploidy (Nakatani et al. 1997).  
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Figure 13 Pathological states such as liver regeneration and 
metabolic overload/oxidative stress that causes liver lesions are 
associated with an increase of polyploidy. Mitogenic stimuli 
are also known to induce an increase of liver polyploidy. From 
Gentric et al. 2012 
2.4 Establishment of liver polyploidy 
Since in mammal organisms the liver at the birth is completely 
composed of mononucleated diploid cells, one of the most 
fascinating questions is how polyploidization is established 
during the post-natal development. This issue represented a 
mystery and only in the last decade some studies have shed 
light on the cellular and molecular mechanisms. However our 
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knowledge about liver polyploidization is still poor. Two 
different cellular mechanisms were identified that contribute to 
the genesis of polyploid hepatocytes. Initially, cell-cell fusion 
was identify as principal mechanism. It has been shown that 
bore-marrow derived hepatocytes transplanted in recipient 
mice with fumarylacetoacetate hydrolase (Fah
-/-
) deficiency can 
repopulate the liver and correct their liver disease 
(Vassilopoulos et al 2003). DNA analysis on repopulating 
hepatocytes in the liver showed that they were heterozygous 
for alleles unique to the donor marrow, in contrast to the 
original homozygous donor cells, indicating homotypic 
hepatocyte fusion occured (Wang at al 2003). Moreover, rare 
events of heterotypic cell fusion were also identified in the 
liver between hepatocytes and myelomonocytic cells, 
presumably liver resident macrophages known as Kuppfer cells 
(Wang et al. 2002). Other interesting studies conducted on 
primary hepatocytes identified failure of cytokinesis as a 
second mechanism for hepatocytes binucleation. Indeed, 
cultured hepatocytes isolated from 10 days old rats progressed 
normally through mitosis with a successfull cytokinesis and 
gave rise solely to diploid progenies. Conversely, cultured 
hepatocytes from 25 days old rats did not complete cytokinesis 
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producing a binucleated progeny cell (Margal-Ducos et al 
2007). Moreover characterization of incomplete cytokinesis in-
vivo and in cultured hepatocytes showed a defect in 
actomyosin ring formation and delocalization of the 
cytokinesis regulators McgRacGAP and RhoA at the equatorial 
cell cortex (Margal-Ducos et al 2007). The stimuli that drive 
hepatocytes binucleation were also investigated by different 
groups. As mentioned above mitogenic stimulation, often 
mediated by soluble factors, is in relation with the ploidy levels 
(Michalopoulos 2007). Studies conducted on TGFα 
overexpressing mice pointed towards the TGFα cytokine as a 
negative regulator of polyploidization. Indeed, 5 week old mice 
livers were analysed for ploidy levels by cytofluorimetry. 
While in normal mice 4n and 8n hepatocytes were prevalent, in 
transgenic TGFα overexpressing mice 2n and 4n cells were 
prevalent without an 8n hepatocyte population (Webber et al 
1994) (Figure 13). In another interesting paper methimazole 
(MMI)-induced hypothyroid rats were analysed for polyploidy 
levels. Two month old MMI treated rats showed lower levels 
of tetraploid liver nuclei than their corresponding untreated 
controls (Torres et al. 1999). Moreover, they found that T3 
thyroid hormone injection in rats produces an increase in 
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tetraploid liver cells (Torres et al. 1999) (Figure 13). These 
data suggested that T3 hormone acts as a positive regulator of 
liver polyploidization. More recent works demonstrated that 
insulin blood levels are  positively related with liver 
binucleation. In this work selective destruction of pancreatic β 
cells by streptozotocin in 4 week old mice led to a drastic 
reduction in binucleated tetraploid hepatocytes (Celton-
Morizur et al 2009, 2010). Conversely, increased insulin blood 
levels stimulated the genesis of binucleated tetraploid 
hepatocytes. (Celton-Morizur et al 2009, 2010). Insulin 
stimulated binucleation by activation of the PIP3/Akt signaling 
pathway regulated the cytokinesis process (Celton-Morizur et 
al 2009, 2010) (Figure 13). In conclusion, liver 
polyploidization during the postnatal development seems to be 
a multifactor process due to soluble factors (cytokines, 
hormons) involved in proliferation and cell cycle regulation.  
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Figure 14 Formation of polyploid hepatocytes during post-
natal development. Insulin blood levels and thyroid hormone 
are positively related to the percentage of tetraploid 
hepatocytes. Whereas transgenic mice overexpressing TGFα 
showed a decrease of tetraploid hepatocytes. 
2.5 Functions of polyploidy hepatocytes 
Polyploidy is not the only feature of hepatocytes. It was shown 
by FISH that both normal human and mouse liver were 
composed of aneuploid cells (Faggioli et al. 2011, Duncan et 
al. 2012). Entire chromosomes were gained and/or lost, and 
structural rearrangements were rarely seen. Chromosome 
counts clustered around the expected number for the different 
ploidy classes: diploid (near 40 chromosomes), tetraploid 
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(near 80 chromosomes) and octaploid (near 160 
chromosomes). Aneuploidy in wild type mice occurred 
randomly as all chromosomes were affected equally (Duncan et 
al 2012). Frequency of liver aneuploidy is age-related and it 
was estimated between 25% in 3 week old mice to 70% in 4-15 
month old mice (Duncan et al. 2010). The origin of hepatic 
aneuploidy was demonstrated injecting octaploid hepatocytes 
isolated from wild type in the recipient liver. Ploidy levels 
were examined upon complete liver repopulation by donor 
hepatocytes. As expected, the liver was repopulated with 
donor-derived octaploid hepatocytes but also tetraploid and 
diploid hepatocytes (Duncan et al. 2010). These important 
experiments demonstrated that hepatocytes were able to 
undergo ploidy reversal. The ploidy reduction can arise from a 
cellular division with a successfull cytokinesis, however 
centrosome number significantly affects the outcome of cell 
division. The four centrosomes of a binucleated cell orient 
along three or four distinct poles, forming a multipolar spindle. 
In a multipolar cell division chromosomes segregate to distinct 
poles randomly, forming three or four genetically different 
nuclei (Duncan et al 2010) (Figure 15). Random chromosome 
distribution would generate highly aneuploid daughters that are 
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likely non-viable. However, it does not seem the case of the 
liver in fact live cell imaging shows that progeny resulting 
from tripolar divisions are, indeed, viable and mitotically 
active. Moreover multipolar spindles can be transient. Pairs of 
centrosomes rapidly cluster, leading to the formation of two 
discrete poles. Nuclear segregation then proceeds in a bipolar 
manner to generate two tetraploid nuclei. However, mitotic 
segregation events such as lagging chromosomes are very 
frequent in this type of cell division and lead to the loss of 
entire chromosomes (Duncan et al 2010) (Figure 15).  
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Figure 15 Mechanisms of formation of aneuploid hepatocytes. 
Proliferative polyploid hepatocytes with extra centrosomes can 
produce multipolar mitosis. A) A transient multipolar spindle is 
resolved in a bipolar spindle by centrosome clustering. 
However, segregation errors such as chromosome lagging are 
frequent. Subsequently a functional cytokinesis produces 
aneuploid progeny cells. B) In a multipolar cellular division 
chromosomes segregate in a random manner, moreover lagging 
chromosomes can also occurs at high frequency. In both 
functional and failing cytokinesis aneuploid cells are generated. 
Examples of multipolar mitosis and segregation errors 
identified in liver cells. (microtubule: green, DNA: blue, 
centrosomes: red) c) bipolar mitosis with clustered 
centrosomes d) tripolar mitosis e) tetrapolar mitosis f) lagging 
chromosome at late telophase. From Duncan et al 2012. 
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The function of aneuploid hepatocytes was studied with elegant 
experiments in Fah−/− mice. This animal model is defective in 
the tyrosine catabolic pathway. Loss of the FAH gene leads to 
the accumulation of toxic metabolites that damage the liver and 
cause death. However, Fah−/− mice can survive if 
supplemented with 2-(2-nitro-4-trifluoro- methylbenzoyl)-1,3-
cyclohexanedione (NTBC) that blocks the pathway upstream 
of FAH or if they are knocked-out for homegentisic acid 
dioxygenase (HGD), an enzyme involved in the tyrosine 
metabolism. Fah−/− Hgd+/− mice were maintained by NTBC 
supplementation until adulthood, and then the drug was 
removed. Normally NTBC withdrawal leads to liver failure and 
death within 2–4 weeks. However after several months of 
NTBC withdrawal normal liver function was restored. Analysis 
of healthy liver tissue in rescued mice showed a complete loss 
of Hgd. Comparative genome hybridization analysis showed 
that that the liver was repopulated with a chromosome specific 
aneuploid population: monosomy of chromosome 16, in which 
the locus Hgd is present (Duncan et al. 2012). In conclusion 
this excellent experiments lead to the idea that liver polyploidy 
is a substrate for the development of aneuploid cells. Wide 
spread aneuploidy is a way to generate genetic variation in a 
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tissue that is continuously subject to different potential 
damages such as in the liver. Specific aneuploid injury-
resistant clones are selected under the selective pressure of 
chronic liver damage and they are useful to restore liver 
functions (Figure 16) 
 
 
Figure 16 Model for development of liver aneuploidy. At birth 
the mammalian liver is completely composed of diploid 
hepatocytes. During the post-natal development and with  
ageing liver is enriched of polyploid and aneuploid 
hepatocytes. During chronic injury, specific aneuploid clones 
are selected to restore the liver functions. Modified from 
Duncan et al 2012. 
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3. Relation between EMT/MET and cytokinesis 
 
It is clear from the previous paragraphs, EMT/MET and 
cytokinesis processes share common effectors that are 
evolutionary conserved among the species. Indeed RhoA 
GTPase is necessary in both processes. During EMT/MET, 
RhoA activity is fundamental in cytoskeleton rearrangements, 
organization and cell motility. In cytokinesis, RhoA is 
necessary for cleavage furrow ingression and completion of 
cytokinesis. Interesting studies in Drosophila demonstrated 
that also the Rho regulatory factors GEF and GAP are 
implicated in both process. The GEF Pebble (ECT2 
mammalian homologue) is required for EMT during the 
Drosophila mesoderm migration. A point mutation in Pebble 
affects the migration during the EMT without cytokinesis 
problems (Schumacher et al. 2004). The migration impaired 
phenotype was rescued by a Pebble truncated protein (missing 
the amino-terminal BRCT domain) however binucleated cells 
were formed at high ratio, demonstrating that Pebble/ECT2 is 
necessary in both EMT and cytokinesis (Smallhorn et al 2004) 
(Figure 17). As mentioned in the paragraph 2.2 (Routes to 
polyploidy), RhoA physically interacts at the equatorial cortex 
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with Ect2, McgRacGAP and the kinesin MKLP1. This 
tetrameric complex is necessary for completion of cytokinesis 
in different organisms including fly, worms and mammals 
(Figure 17). Other studies in the nematode C.elegans 
demonstrate that ZEN-4 (MKLP1 mammalian homologue) and 
CYK-4 (McgRacGAP mammalian homologue) are necessary 
in polarizing cells undergoing MET during pharynx 
morphogenesis (Portereiko et al. 2004) (Figure 17). All these 
observations lead to the interesting hypothesis that the same 
molecular machinery is used in distinct ways, but as a similar 
unit, in cytokinesis and in EMT/MET. Alternatively, regulation 
of Ect2 and McgGapGAP by phosphorylation may drive the 
specificity for the processes (Labouesse 2004) 
 
Figure 17 Common effectors in cytokinesis and EMT/MET 
From Labouesse 2004 
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CHAPTER 2. AIM OF THE WORK 
Although polyploidy has been described in the liver for over 
100 years, hepatocyte polyploidization during the post natal 
development has remained a mystery in the last century. Only 
in the last decade few studies have partially investigated this 
topic indicating the involvement of soluble factors like 
cytokines, hormones and growth factors as main promoters of 
liver polyploidization. TGFα, Thyroid hormone and insulin, 
which have deeply different functions in the organism have 
been demonstrated in-vivo to be involved in the liver 
polyploidy regulation (Webber et al 1994, Torres et al. 1999, 
Celton-Morizur et al 2009). Thus, polyploidization seems to be 
a multifactorial phenomenon and quite difficult to investigate 
in the whole organism. This work aimed to identify the major 
stimuli for hepatocyte polyploidization by initially 
investigating the influence of soluble factors on ploidy levels in 
cell culture in which treatment conditions can be standardized. 
We took advantage of MMH-E14, a hepatocyte cellular model 
developed in our laboratory. Subsequently, results obtained 
from the hepatocyte cell line culture were translated in-vivo in 
wild-type mice. In-vivo analysis was compared with data from 
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cell culture to assess if our experimental cellular model was 
representative for the organisms‟ physiology. Once the 
stimulus for liver polyploidization was identified, the 
molecular mechanism(s) through which it acts were also 
analyzed in the MMH-14 cell line.  
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CHAPTER 3. MATERIAL AND METHODS  
Cellular model 
Met Murine Hepatocytes (MMH-E14) are immortalized, non- 
tumorigenic cells. This cell line was derived from explants of 
14 days post-coitus fetal liver obtained from transgenic mice 
expressing a constitutively active truncated human Met 
receptor (cyto-Met) under the control of  the human α1-
antitrypsin transcription unit (Amicone et al. 1997). MMH-E14 
cells are polarized, epithelial hepatocytes which express all the 
hepatic functions. Making use of the MMH-E14 cell model we 
demonstrated that TGFβ acts as an inducer of EMT also in 
hepatocytes. TGFβ treated MMH-E14 epithelial cells show 
typical features normally associated with an epithelial-to-
mesenchymal transition such as: a fibroblastoid phenotype, 
downregulation of membrane adhesion molecules (E-cadherin, 
ZO-1), downregulation of epithelial differentiation markers 
(HNFs) and liver function gene expression (Albumin), 
activation of the master gene of EMT Snail transcription factor 
(Spagnoli et al. 1998). Furthermore the TGFβ-induced EMT 
results completely reversible after the cytokine withdrawal, 
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showing that these cells represent a good model to study EMT-
MET dynamics in hepatocytes. 
Cell culture and treatments 
The non-tumorigenic murine hepatocytes MMH-E14 (Spagnoli 
et al. 1998) cell line was grown in RPMI (Gibco, USA) 
medium supplemented with 10% FBS, 10 µg/ml Insulin and 50 
ng/ml EGF, 30 ng/ml IGF-2 growth factors, L-glutamine and 
penicillin/streptomycin on collagen I (Transduction 
Laboratories, Lexington, UK) coated dishes (Falcon-BD, 
Franklin Lakes, NJ, USA). Mesothelial Met-5A cells were 
grown in DMEM (Gibco, USA) supplemented with 10% FBS, 
L-glutamine and penicillin/streptomycin on plastic dishes. For 
TGFβ treatments normal medium was supplemented with 10 
ng/ml of this cytokine (Preprotech) for 72 h with or without the 
following inhibitor: 2µM pyrazolopyrimidine PP2 
(Calbiochem, Merck Chemicals Ltd. Beeston, Nottingham, 
UK), 10 µM Src inhibitor, 5 µM LY294002 PI2K inhibitor. 
For TGFβ withdrawal, medium was removed from 72h TGFβ 
treated cells and they were washed once with PBS and after 
normal cell medium was added for further 72h. 
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Transfection and RNA interference 
MMH-E14 cells were transfected with siRNA oligos against 
mouse Snail (sense 50 -GCUCCUUCGU CCUUCUCCU-30 ; 
antisense: 50 -AGGAGAAGGACGAAGGACG-30 ; Sigma-
Aldrich), or GFP by Lipofectamine 2000 (Invitrogen). After 6 
hours of transfection, cells were split and seeded for further 
treatments. 
Analysis of binucleated cells  
Cells were washed in PBS and fixed in glacial methanol for 5 
min at -20°C. After fixation, samples were stained with 5% 
Giemsa water solution for 20 min at room temperature, rinsed 
with water and analyzed for the presence of binucleated cells 
by optical microscopy. 
Immunostaining 
Cells were rinsed in PBS, fixed for 10 min with 4% 
formaldehyde in PBS and permeabilized for 5 min with 0.1% 
Triton-X100. After fixation, coverslips were blocked in PBS 
containing 3% bovine serum albumin for 30 min at 37°C, 
before being processed for immunofluorescence. Antibody 
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dilution was as follows: anti-RhoA-GTP (NewEast Biosciences 
1:400), anti-ECadherin (1:50), anti-Snail (1:50). Secondary 
antibodies conjugated to Alexa-488 or Alexa-594 (Molecular 
Probes) were used as recommended by the supplier. DNA was 
counterstained with 0.1 μg/ml 4'-6'-Diamidino-2-phenylindole 
(DAPI, Sigma). All stained sample were analyzed under a 
Nikon Microphot-FXA microscope equipped with a CCD 
camera and digital images were acquired with Nikon NIS-
elements software. 
Fluorescence microscopy and image analysis  
All preparations were examined under an Nikon Eclipse 
fluorescent microscope equipped with a 20X (0.9 NA) or 40X 
(1.35 NA) oil immersion objective and a CCD camera (Nikon 
Inc.) equipped with a specific filter set. Colour-encoded images 
were acquired using NIS elements software (Nikon Inc.). 
Midbody structures and cell morphology were identified and 
analyzed by phase contrast image. 
In-vivo time-lapse video microscopy 
TGFβ treated or untreated MMH-14 cells were seeded on a 
glass-button collagen I coated micro-dish (Ibidi, Germany) and 
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after 48 h were mounted on a micro-incubator stage (OKO 
Lab, Italy) at 37°C and 5% CO2 for time-lapse analysis. Time-
lapse video microscopy was performed using a Nikon Ti 
Eclipse microscope equipped with a 40X PlanFluor objective 
starting from cells holding single nuclei . Differential 
interference contrast images were acquired every 8 min for 24 
h. Image series acquired were analyzed with NIS Elements 
(Nikon) and ImageJ (rsbweb.nih.gov/ij/) softwares. 
Flow Cytometry Analysis 
Cells were fixed in glacial ethanol for 5 min, washed twice 
with PSB and finally stained with 0.1 µg/µl propidium iodide 
(PI) for 10 min at 37°C. Ten thousand events were acquired for 
each sample using a FACStar Plus fluorescence-activated cell 
sorter (BD Biosciences, San Jose, CA) flow cytometer and 
analyzed by FACS WinMDI software. The amplification scale 
was linear for FSC-H and FL2-A parameters. Photomultiplier 
tension was set as to place the peak corresponding to 2C DNA 
content (G0/G1) at channel 200 in the FL2-H histogram. Cell 
aggregates were carefully gated out using FL2-W versus FL2-
A bivariant graphs. 
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SDS–PAGE and Western blots 
Cells were lysed in RIPA buffer containing protease inhibitors 
(Roche, Monza, IT). Protein concentrations were determined 
with the Bio-Rad assay reagent (Bio-Rad Laboratories, 
Hercules, CA). Equal amounts of protein were separated by 
SDS–PAGE and transferred to nitrocellulose membranes 
(Millipore, MA, USA). Blots were blocked in 5% non-fat milk 
prepared in TBST and incubated overnight with the primary 
antibody. Antibodies against phospho-Src (Tyr416) (Cell 
Signaling, 1:400) and α-tubulin (Santa Cruz Biotechnology, 
CA, USA, 1:1000) were used. Blots were then incubated with 
HRP-conjugated species-specific secondary antibodies (Bio-
Rad, Hercules, CA, USA), followed by enhanced 
chemiluminescence reaction (Pierce Chemical, Rockford, IL). 
RNA extraction, reverse transcription and RT–qPCR 
Total RNA was extracted with NucleoSpin® RNA II kit 
(Macherey–Nagel, Germany) and reverse transcribed with 
MMLV-reverse-transcriptase (Promega, MI, Italy). cDNA was 
amplified by qPCR reaction using BioRad Miniopticon with 
KAPA SYBR® Green FAST qPCR mix 
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(KAPABIOSYSTEMS, Woburn, MA, USA), and the 
following specific primers: mouse Mmp9 forward 5′-
CGCTACCACCTCGAACTTTG-3′ and reverse 5′-
GCCATTCACGTCGTCCTTAT-3′; mouse e-cadherin forward 
5′-ATGCCCCGGAACTCCTTTTC-3′ and reverse 5′-
CAACAGGCAGGCAGCTTTAT-3′; mouse snail forward 5′-
ATGGCTTCTCATCGTCTGCT-3′ and reverse 5′-
GCTCCTCATTCCTTGGGATT-3′; mouse HNF4α forward 5′-
ATCTTCTTTGATCCAGATGCCA -3′ and reverse 5′-
GTTGATGTAATCCTCCAGGC-3′ 
Animal care and treatment and sample preparation. 
Animal care and experiments were carried out according to the 
criteria outlined in the „Guide for the Care and Use of 
Laboratory Animals‟ of the National Academy of Sciences, 
published by the National Institutes of Health (NIH publication 
86–23 revised 1985). Wild-type C57BL6 mice (Charles-River 
Laboratory) were treated by LY2109761 (Cat. S2740, 
Selleckchem) on the days 18-32 post-birth twice daily at the 
dose of 100 mg/Kg body weight. LY2109761 in 1% 
carboxymethyl cellulose (CMC) UPS (Sigma) was orally 
administeed by gavage with specific needle and sham-treated 
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mice received 1% CMC UPS as a control group. At day 33 
post-birth the mice ware sacrificed by cervical dislocation and 
livers were collected and embedded in paraffin. Livers were 
sliced (7µm) by a microtome and attached to polarized glass 
slides. 
Hematoxylin eosin staining on liver tissue slices  
Liver tissue slices were deparaffinized by two xylene washes 
for 10 min and rehydrated by 5 min washes with an alcohol 
series (100%, 95%, 80%, 70% and 50% ethanol). Samples 
were rinsed in distilled water and stained in 1% Harris 
Hematoxylin (Sigma) for 6 min. Samples were then rinsed in 
running tap water for 20 min and quickly destained in acid 
alcohol, rinsed in tap water for 5 min and immersed in Lithium 
Carbonate for 3 sec. Slides were rinsed in tap water for 5 min 
and counterstained with 1% Eosin (Sigma). Finally, slides were 
dehydrated by 3 min washes in 95% and 100% ethanol.  
Ki-67 immunostaining on liver tissue slices  
Liver tissue slices were deparaffinized by two xylene washes 
for 10 min and rehydrated by 5 min washes of 100%, 95%, 
80%, 70% and 50% ethanol. Antigen retrieval was performed 
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in citrate buffer (10mM Sodium citrate, 0.05% Tween20, 
pH=6) for 20 min at 100°C. Liver slices were permeabilized 
with 0.2% Triton X-100 for 5 min and blocked in 10% Bovine 
Serum Albumin in PBS for 30 min at 37°C. After the blocking 
phase, slices were incubated with mouse monoclonal anti-Ki67 
antibody (1:25, BD Bioscience Pharmigen, CA, USA) in 1% 
BSA overnight. Samples were washed 3 times in PBS for 5 
min and incubated with the anti-mouse Alexa Fluor 488 
secondary antibody (Invitrogen, CA, USA). Samples were 
washed 3 time in PBS and counterstained with 0.1 µg/ml 4,6-
diamino-2-phenylindole (Sigma) for 5 min at room 
temperature. Slices were mounted with 70% glycerol and 
analyzed. Ten randomly chosen different fields were digitally 
acquired for each mouse and the number of Ki-67 positive 
cells/ number of total cells were manually counted with Adobe 
Photoshop software. 
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CHAPTER 4. RESULTS 
 
TGFβ induces cytokinesis failure and binucleation in 
MMH-E14 cells 
To investigate a possible involvement of soluble factors in liver 
polyploidization we selected 6 cytokines and growth factors 
known to be involved in liver development and/or in  mass 
liver control: EGF, IGF2, FGF1, FGF-2, Wnt3a and TGFβ. 
MMH-E14 cells were treated for 72h , giemsa stained and 
analyzed for binucleated cells content (Figure 18A). We 
decided to limit our investigation to the cells with two different 
nuclei, even if  binucleated cell analysis represents an 
underestimation of polyploid cells and polyploid 
mononucleates may also form. This because  it is virtually 
impossible to discriminate a tetraploid G1 cell cycle phase 
from a diploid G2 cell cycle phase by both microscopy analysis 
and propidium iodide incorporation. We found that  TGFβ 
induces binucleated cells at a high ratio versus the untreated 
cells (23,3±3% for TGFβ- treated versus 2,1±1,8% for 
untreated, P<0,01) (Figure 18B and 18C). Moreover, TGFβ 
treatment of MMH-E14 cells produces a morphological change 
Results 
68 
 
in which cells acquire spindle shape morphology (Figure 18C). 
In fact we have already shown that TGFβ triggers EMT in 
MMH-E14 (Spagnoli et al. 1999, 2000). In order to assess the 
hepatospecificity of TGFβ-induced binucleation, we perform 
the same treatment on a non -tumorigenic mesothelial cell line 
Met-5A. Also these cells are well known to undergo in EMT in 
response to TGFβ stimulation. However, TGFβ stimulation did 
not induce binucleated cells in Met-5A (Figure 18D). This data 
suggest that the TGFβ-induced binucleation may have a tissue 
specific basis conceivably triggered by different downstream 
pathways.  
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Figure 18. Analysis of binucleation in MMH-E14 cells. (A) 
Percentage of binucleated cells after 72 h treatment with EGF, 
IGF2, FGF1, FGF-2, Wnt3a and TGFβ. (mean ± s.e.m. of 4 
independent experiments) (B) Percentage of binucleates after 
72h TGFβ treatment (mean ± s.e.m. of 4 indipendent 
experiments) (* P(
2
)<0.01). (C) Acquisition of mononucleated 
ephitelial untreated cells andbinucleated spindle cell shape 
after 72 h treatment with TGFβ. Magnification 20x (D) 
Percentage of binucleates after TGFβ-treatment in Met-5A 
cells (mean ± s.e.m. of 3 independent experiments). 
Two different mechanisms have been suggested to  contribute 
to binucleation in hepatocytes: the cell-cell fusion and 
cytokinesis failure (Duncan et al. 2009, Margall-Ducos et al. 
2007) . In order to analyze which mechanism was involved in 
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the production of binucleated cells during TGFβ stimulation we 
performed in-vivo time lapse video microscopy. The last 24 
hours of a 72 hours TGFβ treatment of single mononucleated 
cells  have been recorded. Video analysis revealed that TGFβ 
treated cells were able to progress into the different stages of 
mitosis with kinetics comparable to untreated cells. However, 
the latest cytokinesis stage was incomplete and a regression of 
the cleavage furrow was observed. Cytokinesis failure 
produced a binucleated cell at the next G1 cell cycle phase 
(Figure 19). As mentioned in the introduction, it is well know 
that abortive cytokinesis may arise from structural defects such 
as chromatin trapping in the cleavage furrow zone. This type of 
cytokinesis failure often produces a strong delay in the mitosis 
outcome. Cells may progress in the next G1 phase after a long 
block in cytokinesis stage due to Cyclin B degradation. In our 
experiment, comparable mitosis kinetics within untreated and 
TGFβ treated cells suggest that TGFβ-induced cytokinesis 
failure is a specific cell division program rather than an 
abortive mitosis. 
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Figure 19. In-vivo time lapse video microscopy in the last 24 
hours of 72 hours TGFβ treatment (lower panels) starting from 
single mononucleated cells compared to untreated controls 
(upper panels). Differential interference contrast was acquired 
and kinetic of mitosis was monitoring starting from metaphase 
plate formation. Magnification 40X 
Inhibition of TβR class I and II prevent binucleation in 
mice 
To validate data obtained in  our experimental cellular model 
as representative of the organisms‟ physiology,  we analyzed 
the role of TGFβ in liver polyploidization in C57BL6 mice by 
pharmacological inhibition of the TGFβ receptor (TβR). 
LY2109761 is a novel specific inhibitor of both TβR class I 
and II. This inhibitor can be orally administrated; moreover, 
pharmacodynamics/pharmacokinetics and toxicity data are well 
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known (Melisi et al. 2008; Zhang et al. 2011, Flechsig et al. 
2012). Consistently with previously reported data about the 
weaning timeframe for liver binucleation (Guidotti et al. 2003), 
LY2109761 was in-vivo administered during the days 18-32 
post-birth twice daily at the dose of 100 mg/Kg body weight 
(Figure 20). 
 
Figure 20. Schematic representation of the in-vivo treatment 
schedule in C57BL6-mice. 17days after birth mice were treated 
with 1% CMC (sham-treated group) or 100 mg/kg body weight 
LY2109761in 1% CMC. Mice were sacrificed 32 days after 
birth. CMC, carboxymethyl cellulose. 
Four mice were treated with LY2109761 dissolved in 1% 
carboxymethyl cellulose (CMC) and other four mice received 
1% CMC as a control group. At the 32
nd
 day mice were 
sacrificed and liver tissue slices were scored for binucleated 
cells by microscopical analysis after hematoxylin and eosin 
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staining. LY2109761 treated mice showed a highly significant 
decrease of binucleated cells versus the sham-treated mice (8,7 
±0,23 %versus 26,9 ± 0,99 % respectively; P<0,01) (Figure 
21). TGFβ-mediated cytokinesis failure observed in the MMH-
E14 cell line requires cellular proliferation. To assess a 
possible side effect of LY2109761 on the hepatocytes 
proliferation we performed immunostaining against Ki-67 on 
the liver sections. It is well known that the Ki-67 antigen is 
expressed during all cell cycle phases but it is not present 
during the G0 phase. Ki-67 positive cells in sham-treated mice 
were found to be comparable to Ki-67 positive cells in 
LY2109761-treated mice (Figure 22). The proliferative index 
was around 1%, which is the value reported in literature for 
wild type mice. Overall these data indicate that decrease in 
binucleization ratio in LY2109761 treated mice is due to direct 
effect of TβR inhibition rather than inhibition of liver cells 
proliferation. Moreover, ploidy response to TGFβ cell line is 
representative of the organism‟ physiology. 
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Figure 21. Analysis of binucleated cells in liver tissue sections 
after eosin and hematoxylin (E&H) staining. (A) Microscopical 
images of liver tissue sections of sham-treated mice (1% CMC) 
(left panels) and mice treated with LY2109761 in 1% CMC 
(TβR inhibitor) (right panels). Green dots represent 
mononucleates, red dots represent binucleates. Magnification 
20X (B) Percentage of binucleated cells per mouse. N 
corresponds to the number of cells analyzed. (C) Average of 
the percentage of binucleated cells per treatment group (* 
P(
2
)<0.01). 
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Figure 22. (A) Analysis of proliferation in liver tissue sections 
of sham-treated mice (1% CMC) (upper panels) and mice 
treated with LY2109761 in 1% CMC (TβR inhibitor) (lower 
panels). White arrows indicates Ki-67 positive cells. 
Magnification 20X(B) Percentage of Ki67-positive cells and 
(C) average number of cells per field in liver tissue sections of 
sham-treated mice (1% CMC) and mice treated with 
LY2109761 in 1% CMC. 
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TGFβ mediated binucleation is Src kinase dependent 
In order to analyze which TGFβ downstream pathways were 
involved in binucleation we used pharmacological inhibition of 
two kinases, known to be activated from TGFβ, PI3K and Src. 
To this purpose, double treated TGFβ / LY294002 (PI3K 
inhibitor) and TGFβ / PP2 (Src inhibitor) cells were analyzed 
for binucleated cell formation. While inhibition of PI3K does 
not affect the ratio of binucleated cells, inhibition of Src kinase 
largely rescued the binucleated phenotype observed in TGFβ 
treated cells (Figure 23A). At the dose of 2µM PP2 was able to 
inhibit Src activity. Western blot analysis of TGFβ-, PP2- and 
double –treated cells demonstrated a clear decrease in Src 
phosphorylation at tyrosin 416 after double treatment 
compared to TGFβ-treatment alone(Figure 23B and 23D). 
Double band showed in Figure 23B is due to cross reaction of 
the antibody to different isoforms of the same protein as 
mentioned in the product datasheet and in Yamanashi et al 
1989. As mentioned above, cytokinesis failure requires cell 
proliferation. In order to analyze possible side effects of Src 
inhibition on cellular proliferation, cells were counted at the 
end of each treatment. 72 h TGFβ/PP2 treated cells showed 
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comparable cell numbers of 72 h TGFβ treated cells (Figure 
23C).    
 
Figure 23. (A) Percentage of binucleated cells after treatment 
with LY294002 (PI3K inhibitor), PP2 (Src inhibitor), TGFβ, 
LY294002/ TGFβ and PP2/ TGFβ compared to untreated 
controls.(mean ± s.e.m of 3 independent experiment) (*TGFβ 
versus TGFβ/PP2 P( 2)<0.01) (C) Cell number after PP2-, 
TGFβ- and PP2/TGFβ-treatment compared to untreated 
controls. (B, D) Levels of phosphorylation of Src at Tyr416 in 
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PP2-, TGFβ- and PP2/TGFβ-treated cells compared to 
untreated controls.  
These data suggest the involvement of Src kinase in TGFβ-
dependent binucleation. As said, a  parallel effect of TGFβ 
stimulation in MMH-E14 cells is the triggering of EMT. 
Activation of Smad dependent TGFβ downstream pathways 
leads to EMT process. However, other non-Smad pathways 
may contribute to EMT. To investigate on relation between 
binucleation and the EMT process,  characterization of the cell 
populations upon  different treatments was performed by qPCR 
analysis. . Gene expression analysis of control cells as expected 
revealed  that E-cadherin and HNF4 (epithelial markers) are 
downregulated while  Snail and metalloproteinase 9 (MMP9) 
(mesenchymal markers) are upregulatedupon TGFβ treatment.. 
TGFβ and the Src inhibitor PP2 double treated cells showed  a 
similar transcript profile. (Figure 24). 
Results 
80 
 
 
Figure 24. Gene expression analysis of epithelial markers, E-
Cadherin and HNF4, and mesenchymal markers, Snail and 
MMP9 after treatment for 72 h with PP2, TGFβ and 
PP2/TGFβ. Expression levels are normalized against the 
housekeeping gene L32.  
Immunostaining against E-cadherin in untreated, TGFβ-, PP2-, 
and double-treated cells reveals an E-cadherin switch between 
untreated and TGFβ treated cells. As in TGFβ-treated cells, E-
cadherin is also delocalized from the plasma membrane in 
double-treated cells with TGFβ / PP2 . Moreover no difference 
of E-cadherin localization was found between mononucleated 
and binucleated cells, indicating that both cellular 
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subpopulations are able to undergo in EMT (Figure 25). Taken 
all together, this data indicate that Src activity is not required 
for EMT while it is necessary for the binucleation process 
.  
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Figure 25. Localization of E-Cadherin (red) in PP2-, TGFβ- 
and PP2/ TGFβ double-treated cells (left panels). Arrows 
indicate binucleate cells. DAPI DNA staining is shown in the 
middle panels. Phase contrast images are shown in the right 
panels. Magnification 20X. 
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Binucleation is associated with RhoA GTPase activity 
RhoA GTPase is one of the well known non-Smad downstream 
effectors of TGFβ that is responsible for actin cytoskeleton 
rearrangements. As mentioned in the introduction RhoA may 
be differently regulated in different subcellular compartments 
and  was shown to be activated by the Src kinase. Moreover, it 
is known to be necessary for cytokinesis completion, acting at 
the midbody structure. In order to investigate the involvement 
of RhoA in TGFβ-mediated binucleation the localization of the 
active GTP bound RhoA was analyzed by fluorescence 
microscopy during cytokinesis. In these experiments cells in 
cytokinesis and subcellular mid-body structures were identify 
by phase contrast microscopy. TGFβ treated cells showed a 
higher percentage of delocalization of RhoA-GTP from the 
midbody structure against the control cells. Conversely, the 
ratio of delocalization in double treated TGFβ/PP2 cells was 
comparable to the untreated cells (Figure 26). These data 
suggest that RhoA activity at the midbody is Src dependent and 
it is associated with binucleation in MMH-14 cells.  
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Figure 26. Localization of Rho A-GTP at the midbody 
structure. The upper panels show proper localization while the 
lower panels demonstrate delocalization of Rho A-GTP (green) 
from the midbody. Nuclei are stained with DAPI (blue). The 
graph represents the percentage of cells with Rho A-GTP 
delocalization after treatment during 72 h with PP2, TGFβ and 
PP2/TGFβ (mean ± s.e.m of 3 independent experiments) 
(*CTRL versus TGFβ P( 2)<0.01).  
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Snail-induced EMT is necessary for binucleation 
As mentioned in the introduction, the Snail transcription factor 
is the master gene of the EMT process and is well known to be 
induced by TGFβ. To assess the relation between EMT and 
binucleation, genetic knockout of Snail by RNA interference 
has been performed in TGFβ treated cells. Green fluorescent 
proteins (GFP) RNA interference was used as a control. 
Preliminary data demonstrated that after 72 h of TGFβ 
stimulation, Snail-RNAi cells showed a decrease in the 
formation of binucleated cells compared to the TGFβ treated 
cells (6,6 % versus 19,3 % respectively). However, a slight 
decrease has also been observed in TGFβ treated GFP RNAi 
cells. (Figure 27A). Efficiency of RNA interference was 
assessed by the determination of Snail protein levels. Western 
blot analysis of TGFβ / Snail RNAi cells demonstrated a 
decrease in Snail compared to TGFβ-treated and TGFβ / GFP 
RNAi transfection control cells (Figure 27 B). Gene expression 
analysis of TGFβ / Snail RNAi cells revealed that E-cadherin is 
upregulated compared to the TGFβ –treated and TGFβ / GFP 
RNAi. Moreover, TGFβ / Snail RNAi cells showed an 
epithelial gross morphology (data not shown), indicating that 
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this cell population is epithelial and that it did not undergo 
EMT despite the TGFβ treatment. These preliminary data may 
suggest that the EMT process is a mandatory step for TGFβ-
mediated binucleation, however, further analysis are necessary. 
 
Figure 27 (A) Percentage of binucleated cells after 72h TGFβ 
treatment in Snail RNAi and GFP RNAi transfection control 
compared to TGFβ treated cells and untreated cells. (B) 
Dosimetry of western blot analysis of Snail transcriptional 
factor in TGFβ, TGFβ/Snail RNAi and TGFβ/GFP RNAi 
compared to untreated control cells. (D) Gene expression 
analysis of epithelial marker, E-Cadherin after treatment for 72 
h with TGFβ in Snail RNAi and GFP RNAi cells. Expression 
levels are normalized against the housekeeping gene L32. 
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TGFβ withdrawal increases ploidy grade in MMH-E14 
cells 
It was shown that primary polyploid hepatocytes spontaneously 
reduce their ploidy grade in-vitro, a phenomenon called 
“ploidy conveyor” (Duncan et al. 2010). In our experimental 
system TGFβ works as inducer of polyploidy. We investigated 
ploidy changes after  TGFβ withdrawal. MMH-E14 cells were 
treated with TGFβ for 72 h and they were released for further 
72 h followed by the analysis of binucleation and ploidy. 
Ploidy was assessed by cytofluorimetric analysis of propidium 
iodide incorporation TGFβ released cells showed a decrease in 
ratio of binucleated cells compared to the TGFβ treated cells. 
However, a significant percentage of binucleated cells is still 
retained in this population (17,4 ± 1,5%) (Figure 28A). In 
TGFβ-released cells an increased population with 4C DNA 
content (tetraploid) versus the untreated cells was seen. The 4C 
DNA content peak corresponds to both diploid G2 phase and 
tetraploid G1 cell cycle phase, that are undistinguishable by 
flow cytometry. Moreover, PI incorporation highlighted the 
appearance of a population with 8C DNA content (octaploid) 
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(10,4 %) that is virtually absent in both untreated and TGFβ-
treated cells (Figure 28B and 27C). 
 
Figure 28. (A) Percentage of binucleated cells after treatment 
with TGFβ and TGFβ withdrawal compared to untreated 
controls. (mean ± s.e.m of 3 independent experiment). (B) 
Cytofluorimetric analysis of PI incorporation in TGFβ and 
TGFβ withdrawal compared to untreated controls. (C) 
Results 
89 
 
Quantification of subpopulation with DNA content near 8C for 
the experiment shown in “B” 
Characterization of the epithelial and mesenchymal phenotype 
was also performed. mRNA levels of the whole population 
showed upregulation of the ephitelial marker E-cadherin and 
downregulation of the mesenchymal marker Snail in TGFβ-
released cells compared to TGFβ-treated cells (Figure 29).  
 
Figure 29. Gene expression analysis of E-Cadherin and Snail 
in TGFβ-treated and TGFβ-released cells. Expression levels 
are normalized for the housekeeping gene L32. 
This gene expression data indicated that TGFβ-released cells 
are epithelial cells. This observation was confirmed by 
immunostaining analysis of E-cadherin and Snail transcription 
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factors. In TGFβ-released cells E-cadherin localizes to the 
plasma membrane and Snail nuclear stain was negative. 
Moreover, phase contrast micrographs showed epithelial gross 
morphology. No difference in E-cadherin localization and Snail 
nuclear stain was found between the mononucleated and 
binucleated cellular subpopulations (Figure 30).  
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Localization of E-Cadherin (upper panels) and 
Snail (lower panels) in TGFβ-treated and TGFβ-released cells. 
Arrows indicate binucleated cells. Magnification 20X 
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These data suggested that MMH-E14 cells pretreated with 
TGFβ are committed to polyploidy and they can proliferate 
increasing ploidy grade. Moreover, pretreatment of TGFβ 
generates a polyploidy full epithelial hepatocytes population. 
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CHAPTER 5. DISCUSSION 
The aim of this study was to indentify the major stimulus 
inducing liver polyploidization and to elucidate the pathways 
involved in the regulation of this physiological process. We 
collected evidence indicating TGFβ to be a major inducer of 
polyploidization in hepatocytes. We showed, in fact, that this 
cytokine induces binucleation in the hepatocyte cell line and 
that chemical inhibition of its receptor impairs the 
physiological hepatocyte polyploidization in vivo. Thus in our 
cellular and animal systems TGFβ seems to be the main 
stimulus for hepatocyte binucleation (Figure 31). The MMH-
E14 cell line recapitulates the organisms‟ physiology. Data 
obtained with a non-hepatic epithelial cell line (i.e. 
mesothelium), moreover, indicates this is a largely tissue-
specific effect of TGFβ. 
TGFβ is a pleiotropic cytokine that regulates 
proliferation, differentiation, adhesion, migration, and other 
functions in many cell types. The role of TGFβ as a main 
inducer of EMT in a large variety of epithelial cells, including 
hepatocytes, is well known. In the liver, its role has been well 
described during the regeneration process when it is released 
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from activated hepatic stellate cells (Kalluri and Weinberg 
2009, Xue et al 2013). TGFβ paracrine stimulation induces a 
partial EMT in hepatocytes, useful for cell migration and organ 
remodelling, and appears essential for the control of liver mass. 
Afterwards transitional hepatocytes can undergo MET 
producing new healthy tissue (Kalluri and Weinberg 2009, Xue 
et al 2013). The regeneration process, as mentioned in the 
introduction, is also associated with increased ploidy levels 
(Gentric et al. 2012). Nevertheless, nothing has been known 
about the role of TGFβ in the hepatocytes polyploidization, that 
physiologically occurs during the first month after birth. Here, 
we demonstrated this role and, in addition, we revealed i) 
cytokinesis failure as the main mechanism used by TGFβ to 
induce hepatocyte polyploidization, ii) a Src-dependent 
signalling as the molecular mechanism that hepatocytes use to 
transduce the cytokine signal, iii) the delocalization of the 
GTPase RhoA from the mid-body during last phase of the 
hepatocyte mitosis as a probable main cause of cytokinesis 
failure and iv) the EMT as an instrumental process for 
polyploidization (Figure 31). Particularly intriguing is the 
correlation between EMT/MET and polyploidization because it 
could reveal a novel process in which transdifferentiation 
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events of hepatocytes are involved. Our preliminary data 
regarding interference of the EMT master gene Snail indicate 
that the EMT process is mandatory in TGFβ- mediated 
hepatocyte binucleation.  
Several literature data are in line with this hypothesis. 
RhoA is a common effector of EMT/MET and cytokinesis. 
During cytokinesis RhoA forms a complex with the GEF Ect2, 
the GAP McgRacGAP and with the kinesin MKLP1. During 
EMT RhoA was found to be associated with the Ect2 while 
during MET it is associated with McgRacGAP and MKLP1. It 
was hypothesized that the same molecular machinery is used in 
distinct ways in cytokinesis and EMT/MET (Labousse et al. 
2004). Thus, the relation between cytokinesis failure and 
EMT/MET may be found in the regulation of these shared 
regulatory units (GAP and GEF). In fact, it is well known that 
activities of both Ect2 and McgRacGAP are regulated by 
phosphorylation (Tatsumoto et al. 1999, Minoshima et al. 
2003). Differential phosphorylation states could present a 
possible mechanism to enable regulation of both distinct 
processes, EMT/MET and cytokinesis. The hepato-specificity 
of TGFβ-mediated binucleation was analyzed by stimulating 
with the same cytokine the mesothelial non tumorigenic cell 
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line Met-5A. In this cell line, TGFβ treatment does not induce 
binucleation demonstrating hepatospecificity. We speculate 
that also the hepatospecificity may be a consequence of 
differential regulation of the main complex 
RhoA/Ect2/McgRacGAP in different cell types.  
By TGFβ withdrawal we were able to obtain a full 
epithelial cellular population. These cells, however, have 
increased levels of tetraploid and octaploid classes compared to 
the mesenchymal TGFβ-treated cells, together with the 
presence of binucleated and mononucleated giant cells (Figure 
31). In this scenario TGFβ stimulation uses EMT/MET 
processes as intermediate steps towards a polypoid status 
(Figure 31). This hypothesis is in line with the role that 
EMT/MET plays in building and modeling tissues. 
Recent excellent studies have demonstrated that liver 
polyploidy represents a substrate for the development of 
aneuploid cells and increased genetic variability. Subsequently, 
specific aneuploid injury-resistant clones are selected under the 
selective pressure of chronic liver damage (Duncan et al 2010, 
2012) whereas in all other solid tissues polyploidy has been 
associated to a pre-transformed state (Storchova and Pellman 
2004). Intrinsic numerical chromosome instability (CIN), due 
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to the extra centrosome number in tetraploid cells, triggers the 
formation of a wide-spread aneuploidy that is associated with 
tumor progression and development of a more aggressive 
phenotype (Godhino et al 2009). Indeed, aneuploidy is a 
hallmark of solid tumors (Rajagopalan and Lengauer 2004). 
Under this point of view, liver polyploidy/aneuploidy represent 
a paradox. During the development of hepatocellular 
carcinomas (HCC), a growth shift to a non-polyploidizing 
pattern and expansion of the diploid hepatocytes population has 
been observed in neoplastic nodules (Seglen, 1997). Moreover, 
it has been shown that heterozygous TbR-II mice have 
increased susceptibility to HCC (Im at al. 2001) and that foci of 
transformed hepatocytes in vivo express low or null rate of 
TGFβ receptor (Amicone et al 2002) This data suggested that 
whereas the liver polyploid fraction is functional after liver 
injury, unregulated TGFβ-mediated ploidy changes could 
contribute to tumorigenesis. We believe that this work and 
further analysis about TGF-mediated hepatocyte ploidy 
changes could contribute not only to gaining insight in liver 
physiology but also to a better understanding of 
hepatocarcinoma formation and progression. 
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Figure 31 Proposed model for TGFβ-dependent binucleation 
and polyploidization in hepatocytes. 
References 
99 
 
REFERENCES 
 
Adams, D. H. and B. Eksteen (2006). Aberrant homing of 
mucosal T cells and extra-intestinal manifestations of 
inflammatory bowel disease. Nat Rev Immunol 6(3): 244-
51. 
Amicone, L., F. M. Spagnoli, G. Spath, S. Giordano, C. 
Tommasini, S. Bernardini, V. De Luca, C. Della Rocca, 
M. C. Weiss, P. M. Comoglio and M. Tripodi (1997). 
Transgenic expression in the liver of truncated Met blocks 
apoptosis and permits immortalization of hepatocytes. 
EMBO J 16(3): 495-503. 
Amicone L, Terradillos O, Calvo L, Costabile B, Cicchini C, 
Della Rocca C, Lozupone F, Piacentini M, Buendia MA, 
Tripodi M (2002)  Synergy between truncated c-Met (cyto-
Met) and c-Myc in liver oncogenesis: importance of TGF-
beta signalling in the control of liver homeostasis and 
transformation.Oncogene 21(9):1335-45 
Bhowmick, N. A., M. Ghiassi, A. Bakin, M. Aakre, C. A. 
Lundquist, M. E. Engel, C. L. Arteaga and H. L. Moses 
(2001). Transforming growth factor-beta1 mediates 
epithelial to mesenchymal transdifferentiation through a 
RhoA-dependent mechanism. Mol Biol Cell 12(1): 27-36. 
Brodsky, W. Y., A. M. Arefyeva and I. V. Uryvaeva (1980). 
Mitotic polyploidization of mouse heart myocytes during 
the first postnatal week. Cell Tissue Res 210(1): 133-44. 
Canman, J. C., D. B. Hoffman and E. D. Salmon (2000). The 
role of pre- and post-anaphase microtubules in the 
cytokinesis phase of the cell cycle. Curr Biol 10(10): 611-
4. 
Carmena, M., S. Ruchaud and W. C. Earnshaw (2009). Making 
the Auroras glow: regulation of Aurora A and B kinase 
References 
100 
 
function by interacting proteins. Curr Opin Cell Biol 
21(6): 796-805. 
Celton-Morizur, S. and C. Desdouets (2009). [Cellular 
polyploidy in hepatic tissue: new role of insulin]. Med Sci 
(Paris) 25(6-7): 651-3. 
Celton-Morizur, S. and C. Desdouets (2010). Polyploidization 
of liver cells. Adv Exp Med Biol 676: 123-35. 
Celton-Morizur, S., G. Merlen, D. Couton and C. Desdouets 
(2010). Polyploidy and liver proliferation: central role of 
insulin signaling. Cell Cycle 9(3): 460-6. 
Celton-Morizur, S., G. Merlen, D. Couton, G. Margall-Ducos 
and C. Desdouets (2009). The insulin/Akt pathway 
controls a specific cell division program that leads to 
generation of binucleated tetraploid liver cells in rodents. J 
Clin Invest 119(7): 1880-7. 
Chen, R. H., Y. H. Su, R. L. Chuang and T. Y. Chang (1998). 
Suppression of transforming growth factor-beta-induced 
apoptosis through a phosphatidylinositol 3-kinase/Akt-
dependent pathway. Oncogene 17(15): 1959-68. 
Cho, H. J., K. E. Baek, S. Saika, M. J. Jeong and J. Yoo 
(2007). Snail is required for transforming growth factor-
beta-induced epithelial-mesenchymal transition by 
activating PI3 kinase/Akt signal pathway. Biochem 
Biophys Res Commun 353(2): 337-43. 
Choi, S. S. and A. M. Diehl (2009). Epithelial-to-mesenchymal 
transitions in the liver. Hepatology 50(6): 2007-13. 
Comai, L. (2005). The advantages and disadvantages of being 
polyploid. Nat Rev Genet 6(11): 836-46. 
Duncan, A. W., A. E. Hanlon Newell, W. Bi, M. J. Finegold, S. 
B. Olson, A. L. Beaudet and M. Grompe (2012). 
Aneuploidy as a mechanism for stress-induced liver 
adaptation. J Clin Invest 122(9): 3307-15. 
References 
101 
 
Duncan, A. W., A. E. Hanlon Newell, L. Smith, E. M. Wilson, 
S. B. Olson, M. J. Thayer, S. C. Strom and M. Grompe 
(2012). Frequent aneuploidy among normal human 
hepatocytes. Gastroenterology 142(1): 25-8. 
Duncan, A. W., R. D. Hickey, N. K. Paulk, A. J. Culberson, S. 
B. Olson, M. J. Finegold and M. Grompe (2009). Ploidy 
reductions in murine fusion-derived hepatocytes. PLoS 
Genet 5(2): e1000385. 
Duncan, A. W., M. H. Taylor, R. D. Hickey, A. E. Hanlon 
Newell, M. L. Lenzi, S. B. Olson, M. J. Finegold and M. 
Grompe (2010). The ploidy conveyor of mature 
hepatocytes as a source of genetic variation. Nature 
467(7316): 707-10. 
Edlund, S., S. Y. Lee, S. Grimsby, S. Zhang, P. Aspenstrom, C. 
H. Heldin and M. Landstrom (2005). Interaction between 
Smad7 and beta-catenin: importance for transforming 
growth factor beta-induced apoptosis. Mol Cell Biol 25(4): 
1475-88. 
Eggert, U. S., T. J. Mitchison and C. M. Field (2006). Animal 
cytokinesis: from parts list to mechanisms. Annu Rev 
Biochem 75: 543-66. 
Ehrlich, M., D. Horbelt, B. Marom, P. Knaus and Y. I. Henis 
(2011). Homomeric and heteromeric complexes among 
TGF-beta and BMP receptors and their roles in signaling. 
Cell Signal 23(9): 1424-32. 
Eliades, A., N. Papadantonakis and K. Ravid (2010). New roles 
for cyclin E in megakaryocytic polyploidization. J Biol 
Chem 285(24): 18909-17. 
Faggioli, F., P. Vezzoni and C. Montagna (2011). Single-cell 
analysis of ploidy and centrosomes underscores the 
peculiarity of normal hepatocytes. PLoS One 6(10): 
e26080. 
References 
102 
 
Fausto, N. and J. S. Campbell (2003). The role of hepatocytes 
and oval cells in liver regeneration and repopulation. Mech 
Dev 120(1): 117-30. 
Fausto, N., J. S. Campbell and K. J. Riehle (2006). Liver 
regeneration. Hepatology 43(2 Suppl 1): S45-53. 
Flechsig, P., M. Dadrich, S. Bickelhaupt, J. Jenne, K. Hauser, 
C. Timke, P. Peschke, E. W. Hahn, H. J. Grone, J. 
Yingling, M. Lahn, U. Wirkner and P. E. Huber (2012). 
LY2109761 attenuates radiation-induced pulmonary 
murine fibrosis via reversal of TGF-beta and BMP-
associated proinflammatory and proangiogenic signals. 
Clin Cancer Res 18(13): 3616-27. 
Fuchs, B. C., T. Fujii, J. D. Dorfman, J. M. Goodwin, A. X. 
Zhu, M. Lanuti and K. K. Tanabe (2008). Epithelial-to-
mesenchymal transition and integrin-linked kinase mediate 
sensitivity to epidermal growth factor receptor inhibition 
in human hepatoma cells. Cancer Res 68(7): 2391-9. 
Gentric, G., S. Celton-Morizur and C. Desdouets (2012). 
Polyploidy and liver proliferation. Clin Res Hepatol 
Gastroenterol 36(1): 29-34. 
Gentric, G., C. Desdouets and S. Celton-Morizur (2012). 
Hepatocytes polyploidization and cell cycle control in liver 
physiopathology. Int J Hepatol 2012: 282430. 
Germain, L., M. J. Blouin and N. Marceau (1988). Biliary 
epithelial and hepatocytic cell lineage relationships in 
embryonic rat liver as determined by the differential 
expression of cytokeratins, alpha-fetoprotein, albumin, and 
cell surface-exposed components. Cancer Res 48(17): 
4909-18. 
Godinho, S. A., M. Kwon and D. Pellman (2009). Centrosomes 
and cancer: how cancer cells divide with too many 
centrosomes. Cancer Metastasis Rev 28(1-2): 85-98. 
References 
103 
 
Gorla, G. R., H. Malhi and S. Gupta (2001). Polyploidy 
associated with oxidative injury attenuates proliferative 
potential of cells. J Cell Sci 114(Pt 16): 2943-51. 
Grunert, S., M. Jechlinger and H. Beug (2003). Diverse cellular 
and molecular mechanisms contribute to epithelial 
plasticity and metastasis. Nat Rev Mol Cell Biol 4(8): 657-
65. 
Guidotti, J. E., O. Bregerie, A. Robert, P. Debey, C. Brechot 
and C. Desdouets (2003). Liver cell polyploidization: a 
pivotal role for binuclear hepatocytes. J Biol Chem 
278(21): 19095-101. 
Gupta, S. (2000). Hepatic polyploidy and liver growth control. 
Semin Cancer Biol 10(3): 161-71. 
Gurtner, G. C., S. Werner, Y. Barrandon and M. T. Longaker 
(2008). Wound repair and regeneration. Nature 453(7193): 
314-21. 
Hartsough, M. T. and K. M. Mulder (1995). Transforming 
growth factor beta activation of p44mapk in proliferating 
cultures of epithelial cells. J Biol Chem 270(13): 7117-24. 
Hugo, H., M. L. Ackland, T. Blick, M. G. Lawrence, J. A. 
Clements, E. D. Williams and E. W. Thompson (2007). 
Epithelial--mesenchymal and mesenchymal--epithelial 
transitions in carcinoma progression. J Cell Physiol 
213(2): 374-83. 
Im, Y. H., H. T. Kim, I. Y. Kim, V. M. Factor, K. B. Hahm, M. 
Anzano, J. J. Jang, K. Flanders, D. C. Haines, S. S. 
Thorgeirsson, A. Sizeland and S. J. Kim (2001). 
Heterozygous mice for the transforming growth factor-beta 
type II receptor gene have increased susceptibility to 
hepatocellular carcinogenesis. Cancer Res 61(18): 6665-8. 
Kaimori, A., J. Potter, J. Y. Kaimori, C. Wang, E. Mezey and 
A. Koteish (2007). Transforming growth factor-beta1 
References 
104 
 
induces an epithelial-to-mesenchymal transition state in 
mouse hepatocytes in vitro. J Biol Chem 282(30): 22089-
101. 
Kalluri, R. (2009). EMT: when epithelial cells decide to 
become mesenchymal-like cells. J Clin Invest 119(6): 
1417-9. 
Kalluri, R. and R. A. Weinberg (2009). The basics of 
epithelial-mesenchymal transition. J Clin Invest 119(6): 
1420-8. 
Kamijo, K., N. Ohara, M. Abe, T. Uchimura, H. Hosoya, J. S. 
Lee and T. Miki (2006). Dissecting the role of Rho-
mediated signaling in contractile ring formation. Mol Biol 
Cell 17(1): 43-55. 
Kretzschmar, M., J. Doody, I. Timokhina and J. Massague 
(1999). A mechanism of repression of TGFbeta/ Smad 
signaling by oncogenic Ras. Genes Dev 13(7): 804-16. 
Kurinna, S., S. A. Stratton, Z. Coban, J. M. Schumacher, M. 
Grompe, A. W. Duncan and M. C. Barton (2013). p53 
regulates a mitotic transcription program and determines 
ploidy in normal mouse liver. Hepatology 57(5): 2004-13. 
Labouesse, M. (2004). Epithelium-mesenchyme: a balancing 
act of RhoGAP and RhoGEF. Curr Biol 14(13): R508-10. 
Lamouille, S. and R. Derynck (2007). Cell size and invasion in 
TGF-beta-induced epithelial to mesenchymal transition is 
regulated by activation of the mTOR pathway. J Cell Biol 
178(3): 437-51. 
Lamouille, S. and R. Derynck (2010). Emergence of the 
phosphoinositide 3-kinase-Akt-mammalian target of 
rapamycin axis in transforming growth factor-beta-induced 
epithelial-mesenchymal transition. Cells Tissues Organs 
193(1-2): 8-22. 
Lapham, L. W. (1968). Tetraploid DNA content of Purkinje 
References 
105 
 
neurons of human cerebellar cortex. Science 159(3812): 
310-2. 
Lilly, M. A. and R. J. Duronio (2005). New insights into cell 
cycle control from the Drosophila endocycle. Oncogene 
24(17): 2765-75. 
Maeda, M., Y. Shintani, M. J. Wheelock and K. R. Johnson 
(2006). Src activation is not necessary for transforming 
growth factor (TGF)-beta-mediated epithelial to 
mesenchymal transitions (EMT) in mammary epithelial 
cells. PP1 directly inhibits TGF-beta receptors I and II. J 
Biol Chem 281(1): 59-68. 
Margall-Ducos, G., S. Celton-Morizur, D. Couton, O. Bregerie 
and C. Desdouets (2007). Liver tetraploidization is 
controlled by a new process of incomplete cytokinesis. J 
Cell Sci 120(Pt 20): 3633-9. 
Matsuura, I., G. Wang, D. He and F. Liu (2005). Identification 
and characterization of ERK MAP kinase phosphorylation 
sites in Smad3. Biochemistry 44(37): 12546-53. 
Melendez, J., K. Stengel, X. Zhou, B. K. Chauhan, M. 
Debidda, P. Andreassen, R. A. Lang and Y. Zheng RhoA 
GTPase is dispensable for actomyosin regulation but is 
essential for mitosis in primary mouse embryonic 
fibroblasts. J Biol Chem 286(17): 15132-7. 
Melisi, D., S. Ishiyama, G. M. Sclabas, J. B. Fleming, Q. Xia, 
G. Tortora, J. L. Abbruzzese and P. J. Chiao (2008). 
LY2109761, a novel transforming growth factor beta 
receptor type I and type II dual inhibitor, as a therapeutic 
approach to suppressing pancreatic cancer metastasis. Mol 
Cancer Ther 7(4): 829-40. 
Meserve, J. H. and R. J. Duronio (2012). Atypical E2Fs drive 
atypical cell cycles. Nat Cell Biol 14(11): 1124-5. 
Minoshima, Y., T. Kawashima, K. Hirose, Y. Tonozuka, A. 
References 
106 
 
Kawajiri, Y. C. Bao, X. Deng, M. Tatsuka, S. Narumiya, 
W. S. May, Jr., T. Nosaka, K. Semba, T. Inoue, T. Satoh, 
M. Inagaki and T. Kitamura (2003). Phosphorylation by 
aurora B converts MgcRacGAP to a RhoGAP during 
cytokinesis. Dev Cell 4(4): 549-60. 
Morillo, S. M., P. Escoll, A. de la Hera and J. M. Frade (2010). 
Somatic tetraploidy in specific chick retinal ganglion cells 
induced by nerve growth factor. Proc Natl Acad Sci U S A 
107(1): 109-14. 
Moustakas, A. and C. H. Heldin (2007). Signaling networks 
guiding epithelial-mesenchymal transitions during 
embryogenesis and cancer progression. Cancer Sci 98(10): 
1512-20. 
Mulder, K. M. and S. L. Morris (1992). Activation of p21ras 
by transforming growth factor beta in epithelial cells. J 
Biol Chem 267(8): 5029-31. 
Muramatsu, Y., T. Yamada, D. H. Moralejo, H. Mochizuki, K. 
Sogawa and K. Matsumoto (2000). Increased polyploid 
incidence is associated with abnormal copper 
accumulation in the liver of LEC mutant rat. Res Commun 
Mol Pathol Pharmacol 107(1-2): 129-36. 
Nakatani, T., M. Inouye and O. Mirochnitchenko (1997). 
Overexpression of antioxidant enzymes in transgenic mice 
decreases cellular ploidy during liver regeneration. Exp 
Cell Res 236(1): 137-46. 
Nieto, M. A. (2009). Epithelial-Mesenchymal Transitions in 
development and disease: old views and new perspectives. 
Int J Dev Biol 53(8-10): 1541-7. 
Nishimura, Y. and S. Yonemura (2006). Centralspindlin 
regulates ECT2 and RhoA accumulation at the equatorial 
cortex during cytokinesis. J Cell Sci 119(Pt 1): 104-14. 
Otto, S. P. (2007). The evolutionary consequences of 
References 
107 
 
polyploidy. Cell 131(3): 452-62. 
Ozdamar, B., R. Bose, M. Barrios-Rodiles, H. R. Wang, Y. 
Zhang and J. L. Wrana (2005). Regulation of the polarity 
protein Par6 by TGFbeta receptors controls epithelial cell 
plasticity. Science 307(5715): 1603-9. 
Pagan, R., I. Martin, M. Llobera and S. Vilaro (1997). 
Epithelial-mesenchymal transition of cultured rat neonatal 
hepatocytes is differentially regulated in response to 
epidermal growth factor and dimethyl sulfoxide. 
Hepatology 25(3): 598-606. 
Pagan, R., A. Sanchez, I. Martin, M. Llobera, I. Fabregat and 
S. Vilaro (1999). Effects of growth and differentiation 
factors on the epithelial-mesenchymal transition in 
cultured neonatal rat hepatocytes. J Hepatol 31(5): 895-
904. 
Papadimitriou, E., D. Kardassis, A. Moustakas and C. 
Stournaras (2011). TGFbeta-induced early activation of 
the small GTPase RhoA is Smad2/3-independent and 
involves Src and the guanine nucleotide exchange factor 
Vav2. Cell Physiol Biochem 28(2): 229-38. 
Papadimitriou, E., E. Vasilaki, C. Vorvis, D. Iliopoulos, A. 
Moustakas, D. Kardassis and C. Stournaras (2012). 
Differential regulation of the two RhoA-specific GEF 
isoforms Net1/Net1A by TGF-beta and miR-24: role in 
epithelial-to-mesenchymal transition. Oncogene 31(23): 
2862-75. 
Paulk, N. K., K. Wursthorn, A. Haft, C. Pelz, G. Clarke, A. H. 
Newell, S. B. Olson, C. O. Harding, M. J. Finegold, R. L. 
Bateman, J. F. Witte, R. McClard and M. Grompe (2012). 
In vivo selection of transplanted hepatocytes by 
pharmacological inhibition of fumarylacetoacetate 
hydrolase in wild-type mice. Mol Ther 20(10): 1981-7. 
References 
108 
 
Peinado, H., D. Olmeda and A. Cano (2007). Snail, Zeb and 
bHLH factors in tumour progression: an alliance against 
the epithelial phenotype? Nat Rev Cancer 7(6): 415-28. 
Peinado, H., M. Quintanilla and A. Cano (2003). Transforming 
growth factor beta-1 induces snail transcription factor in 
epithelial cell lines: mechanisms for epithelial 
mesenchymal transitions. J Biol Chem 278(23): 21113-23. 
Piekny, A., M. Werner and M. Glotzer (2005). Cytokinesis: 
welcome to the Rho zone. Trends Cell Biol 15(12): 651-8. 
Portereiko, M. F., J. Saam and S. E. Mango (2004). ZEN-
4/MKLP1 is required to polarize the foregut epithelium. 
Curr Biol 14(11): 932-41. 
Rahimi, R. A. and E. B. Leof (2007). TGF-beta signaling: a 
tale of two responses. J Cell Biochem 102(3): 593-608. 
Rajagopalan, H. and C. Lengauer (2004). Aneuploidy and 
cancer. Nature 432(7015): 338-41. 
Ravid, K., J. Lu, J. M. Zimmet and M. R. Jones (2002). Roads 
to polyploidy: the megakaryocyte example. J Cell Physiol 
190(1): 7-20. 
Remy, I., A. Montmarquette and S. W. Michnick (2004). 
PKB/Akt modulates TGF-beta signalling through a direct 
interaction with Smad3. Nat Cell Biol 6(4): 358-65. 
Savagner, P. (2001). Leaving the neighborhood: molecular 
mechanisms involved during epithelial-mesenchymal 
transition. Bioessays 23(10): 912-23. 
Schumacher, S., T. Gryzik, S. Tannebaum and H. A. Muller 
(2004). The RhoGEF Pebble is required for cell shape 
changes during cell migration triggered by the Drosophila 
FGF receptor Heartless. Development 131(11): 2631-40. 
Seglen, P. O. (1997). DNA ploidy and autophagic protein 
degradation as determinants of hepatocellular growth and 
survival. Cell Biol Toxicol 13(4-5): 301-15. 
References 
109 
 
Shen, X., J. Li, P. P. Hu, D. Waddell, J. Zhang and X. F. Wang 
(2001). The activity of guanine exchange factor NET1 is 
essential for transforming growth factor-beta-mediated 
stress fiber formation. J Biol Chem 276(18): 15362-8. 
Shiojiri, N., J. M. Lemire and N. Fausto (1991). Cell lineages 
and oval cell progenitors in rat liver development. Cancer 
Res 51(10): 2611-20. 
Sigal, S. H., P. Rajvanshi, G. R. Gorla, R. P. Sokhi, R. Saxena, 
D. R. Gebhard, Jr., L. M. Reid and S. Gupta (1999). Partial 
hepatectomy-induced polyploidy attenuates hepatocyte 
replication and activates cell aging events. Am J Physiol 
276(5 Pt 1): G1260-72. 
Si-Tayeb, K., F. P. Lemaigre and S. A. Duncan Organogenesis 
and development of the liver. Dev Cell 18(2): 175-89. 
Smallhorn, M., M. J. Murray and R. Saint (2004). The 
epithelial-mesenchymal transition of the Drosophila 
mesoderm requires the Rho GTP exchange factor Pebble. 
Development 131(11): 2641-51. 
Soeda, S., Y. Nakayama, T. Honda, A. Aoki, N. Tamura, K. 
Abe, Y. Fukumoto and N. Yamaguchi (2013). v-Src causes 
delocalization of Mklp1, Aurora B, and INCENP from the 
spindle midzone during cytokinesis failure. Exp Cell Res 
319(10): 1382-97. 
Song, K., H. Wang, T. L. Krebs and D. Danielpour (2006). 
Novel roles of Akt and mTOR in suppressing TGF-
beta/ALK5-mediated Smad3 activation. Embo J 25(1): 58-
69. 
Spagnoli, F. M., L. Amicone, M. Tripodi and M. C. Weiss 
(1998). Identification of a bipotential precursor cell in 
hepatic cell lines derived from transgenic mice expressing 
cyto-Met in the liver. J Cell Biol 143(4): 1101-12. 
Spagnoli, F. M., C. Cicchini, M. Tripodi and M. C. Weiss 
References 
110 
 
(2000). Inhibition of MMH (Met murine hepatocyte) cell 
differentiation by TGF(beta) is abrogated by pre-treatment 
with the heritable differentiation effector FGF1. J Cell Sci 
113 ( Pt 20): 3639-47. 
Steigemann, P., C. Wurzenberger, M. H. Schmitz, M. Held, J. 
Guizetti, S. Maar and D. W. Gerlich (2009). Aurora B-
mediated abscission checkpoint protects against 
tetraploidization. Cell 136(3): 473-84. 
Stocker, E., H. K. Wullstein and G. Brau (1973). [Capacity of 
regeneration in liver epithelia of juvenile, repeated 
partially hepatectomized rats. Autoradiographic studies 
after continous infusion of 3H-thymidine (author's transl)]. 
Virchows Arch B Cell Pathol 14(2): 93-103. 
Storchova, Z., A. Breneman, J. Cande, J. Dunn, K. Burbank, E. 
O'Toole and D. Pellman (2006). Genome-wide genetic 
analysis of polyploidy in yeast. Nature 443(7111): 541-7. 
Storchova, Z. and D. Pellman (2004). From polyploidy to 
aneuploidy, genome instability and cancer. Nat Rev Mol 
Cell Biol 5(1): 45-54. 
Tatsumoto, T., X. Xie, R. Blumenthal, I. Okamoto and T. Miki 
(1999). Human ECT2 is an exchange factor for Rho 
GTPases, phosphorylated in G2/M phases, and involved in 
cytokinesis. J Cell Biol 147(5): 921-8. 
Taub, R. (2004). Liver regeneration: from myth to mechanism. 
Nat Rev Mol Cell Biol 5(10): 836-47. 
Taylor, M. V. (2002). Muscle differentiation: how two cells 
become one. Curr Biol 12(6): R224-8. 
Thiery, J. P., H. Acloque, R. Y. Huang and M. A. Nieto (2009). 
Epithelial-mesenchymal transitions in development and 
disease. Cell 139(5): 871-90. 
Torres, S., B. P. Diaz, J. J. Cabrera, J. C. Diaz-Chico, B. N. 
Diaz-Chico and A. Lopez-Guerra (1999). Thyroid 
References 
111 
 
hormone regulation of rat hepatocyte proliferation and 
polyploidization. Am J Physiol 276(1 Pt 1): G155-63. 
Toyoda, H., O. Bregerie, A. Vallet, B. Nalpas, G. Pivert, C. 
Brechot and C. Desdouets (2005). Changes to hepatocyte 
ploidy and binuclearity profiles during human chronic 
viral hepatitis. Gut 54(2): 297-302. 
Troadec, M. B., B. Courselaud, L. Detivaud, C. Haziza-Pigeon, 
P. Leroyer, P. Brissot and O. Loreal (2006). Iron overload 
promotes Cyclin D1 expression and alters cell cycle in 
mouse hepatocytes. J Hepatol 44(2): 391-9. 
Ullah, Z., M. J. Kohn, R. Yagi, L. T. Vassilev and M. L. 
DePamphilis (2008). Differentiation of trophoblast stem 
cells into giant cells is triggered by p57/Kip2 inhibition of 
CDK1 activity. Genes Dev 22(21): 3024-36. 
Valdes, F., A. M. Alvarez, A. Locascio, S. Vega, B. Herrera, 
M. Fernandez, M. Benito, M. A. Nieto and I. Fabregat 
(2002). The epithelial mesenchymal transition confers 
resistance to the apoptotic effects of transforming growth 
factor Beta in fetal rat hepatocytes. Mol Cancer Res 1(1): 
68-78. 
Vassilopoulos, G., P. R. Wang and D. W. Russell (2003). 
Transplanted bone marrow regenerates liver by cell fusion. 
Nature 422(6934): 901-4. 
Vignery, A. (2000). Osteoclasts and giant cells: macrophage-
macrophage fusion mechanism. Int J Exp Pathol 81(5): 
291-304. 
Wang, X., E. Montini, M. Al-Dhalimy, E. Lagasse, M. 
Finegold and M. Grompe (2002). Kinetics of liver 
repopulation after bone marrow transplantation. Am J 
Pathol 161(2): 565-74. 
Wang, X., H. Willenbring, Y. Akkari, Y. Torimaru, M. Foster, 
M. Al-Dhalimy, E. Lagasse, M. Finegold, S. Olson and M. 
References 
112 
 
Grompe (2003). Cell fusion is the principal source of 
bone-marrow-derived hepatocytes. Nature 422(6934): 897-
901. 
Webber, E. M., J. C. Wu, L. Wang, G. Merlino and N. Fausto 
(1994). Overexpression of transforming growth factor-
alpha causes liver enlargement and increased hepatocyte 
proliferation in transgenic mice. Am J Pathol 145(2): 398-
408. 
Winkelmann, M., P. Pfitzer and W. Schneider (1987). 
Significance of polyploidy in megakaryocytes and other 
cells in health and tumor disease. Klin Wochenschr 
65(23): 1115-31. 
Xue, Z. F., X. M. Wu and M. Liu Hepatic regeneration and the 
epithelial to mesenchymal transition. World J 
Gastroenterol 19(9): 1380-6. 
Yi, J. Y., I. Shin and C. L. Arteaga (2005). Type I transforming 
growth factor beta receptor binds to and activates 
phosphatidylinositol 3-kinase. J Biol Chem 280(11): 
10870-6. 
Yuce, O., A. Piekny and M. Glotzer (2005). An ECT2-
centralspindlin complex regulates the localization and 
function of RhoA. J Cell Biol 170(4): 571-82. 
Zeisberg, M., C. Yang, M. Martino, M. B. Duncan, F. Rieder, 
H. Tanjore and R. Kalluri (2007). Fibroblasts derive from 
hepatocytes in liver fibrosis via epithelial to mesenchymal 
transition. J Biol Chem 282(32): 23337-47. 
Zhang, M., S. Kleber, M. Rohrich, C. Timke, N. Han, J. 
Tuettenberg, A. Martin-Villalba, J. Debus, P. Peschke, U. 
Wirkner, M. Lahn and P. E. Huber (2011). Blockade of 
TGF-beta signaling by the TGFbetaR-I kinase inhibitor 
LY2109761 enhances radiation response and prolongs 
survival in glioblastoma. Cancer Res 71(23): 7155-67. 
References 
113 
 
Zhang, Y., Z. Wang, D. X. Liu, M. Pagano and K. Ravid 
(1998). Ubiquitin-dependent degradation of cyclin B is 
accelerated in polyploid megakaryocytes. J Biol Chem 
273(3): 1387-92. 
References 
114 
 
ACKNOWLEDGEMENTS 
 

